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1 Introduction 
1.1 Peroxisomes – essential organelles 
One of the biggest advantages eukaryotic cells have is their compartmentalization, optimizing 
the metabolic fluxes. Additionally, the separation of enzymatic pathways such as the 
catabolism and anabolism of fatty acids provides an easy way of regulating different reactions 
efficiently. A variety of organelles has evolved to make this possible. Among those are 
peroxisomes, small compared to other organelles such as the endoplasmic reticulum (ER) or 
mitochondria since their size ranges from 0.1 to 0.5µm in diameter. Peroxisomes are single 
membrane-bound organelles and do not contain DNA. Together with glyoxysomes and 
glycosomes they belong to the microbody family.  
Peroxisomes enclose several biochemical pathways, and are essential for most 
organisms. They oxidize very long chain fatty acids (VLCFA) through  β-oxidation, they 
participate in the metabolism of ether lipids, such as plasmalogens and nitrogen bases (Figure 
1, van den Bosch et al., 1992, Lazarow, 1995, Subramani, 1998, reviewed by Wanders and 
Waterham, 2006).  Moreover, peroxisomes contain enzymes involved in the catabolism of 
reactive oxygen species (ROS) or derivatives, compounds, which accumulation has been 
correlated with ageing (reviewed by Perichon et al., 1998). The ability to degrade H2O2 with 
catalase gave rise to the name peroxisomes (De Duve and Baudhuin, 1966).  
 
 
Figure 1: Major metabolic pathways in peroxisomes of  
the mammalian liver, from Schrader and Fahimi, 2008 
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These multiple tasks make it clear that peroxisomes need to be versatile in order to adapt to 
the varying cellular requirements. In the yeast Saccharomyces cerevisiae, the need for 
peroxisomal function arises when fatty acids are provided as sole carbon source. As compared 
to fermenting cells using glucose, these cells do require peroxisomal β-oxidation to grow. 
This requirement for peroxisomal function leads to biogenesis and proliferation of these 
organelles (Veenhuis et al., 1987). Despite the fact that mammalian cells always contain many 
peroxisomes, their number, size and shape can vary in different tissues or cellular conditions. 
Moreover, in rodents peroxisomes are highly inducible by hypolipidemic drugs such as 
fibrates or plasticizers. (Nakajima et al., 2002). 
In human, the loss of functional peroxisomes leads to dramatic disorders. This can be 
due to either an aberrant formation of peroxisomes (peroxisomal biogenesis disorders-PBDs) 
or to the deficiency of one specific peroxisomal protein (e.g. hyperoxaluria 1, Gould and 
Valle, 2000; Moser et al., 1995). The PBDs have been classified into 13 complementation 
groups (CGs) with mutations at different loci. Some broadly known diseases are the 
Zellweger syndrome, Refsum disease or neonatal adrenoleukodystrophy (Wierzbicki et al., 
2002, Moser et al., 1984, Santos et al., 1988). Although some pharmacological advances have 
been made (such as dietary supplementation with peroxisomal proliferators, McGuinness et 
al., 2000; Wei et al., 2000, Kemp et al., 1998), these recessive hereditary diseases are mostly 
lethal.  
 
The use of yeasts as model organisms has allowed to perform genetic screens and led to the 
identification of genes coding for proteins involved in the biogenesis and proliferation of 
peroxisomes (Erdmann et al., 1989, Vizeacoumar Vizeacoumar et al., 2004). Today, 31 of 
these proteins are known, that have been called peroxins and are encoded on the PEX genes 
(Table 1, Distel et al., 1996, reviewed by Platta and Erdmann, 2007, Brocard and Hartig, 
2007). Note, that not all peroxins are present in every organism as listed in Table 1. 
Additionally, signal sequences were discovered to traffic newly synthesized proteins to the 
peroxisomal matrix (Gould et al., 1988; Subramani, 1998; Subramani et al., 2000). Most 
peroxisomal proteins are targeted to peroxisomes through the peroxisomal targeting signal 1 
(PTS1), which originally was thought to consist of the consensus tripeptide (S/A/C)-(K/R/H)-
(L/M) at the extreme C-terminus of the cargo protein (Gould et al., 1989). 
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Table 1: The Peroxins; AAA: ATPase associated with diverse cellular activities; CAAX-box: farnesylation 
motif; DysF: Dysferlin domain; PXXP: class II SH3 interacting motif; RING: really interesting new gene; 
SH3: Src homology 3; TPR: tetratricopeptide repeat; Ubc: ubiquitin-conjugating enzyme; WD40: 40 
amino acid long domain containing conserved Trp-Asp; ZS: Zellweger syndrome, NALD: neonatal 
adrenoleukodystrophy, IRD: infantile Refsum disease, RCDP: rhizomelic chondrodysplasia punctata; 
adapted from Brocard and Hartig, 2007; Platta and Erdmann, 2007 
 
 
 
A minor part of matrix proteins is targeted through PTS2, an N-terminal nonapeptide with 
(R/K)-(L/I/V)-X5-(Q/H)-(L/I/V) as consensus sequence (Osumi et al., 1991, Swinkels et al., 
1991). Interestingly, the presence of one of these signals does not necessarily imply the 
localization to peroxisomes. For instance, despite exhibiting a PTS1, phosphomevalonate 
kinase was shown to be cytosolic (Hogenboom et al., 2004). Furthermore, recent studies have 
revealed, that PTS1 should rather be considered as dodecamer able to interact with the 
tetratricopeptide repeat (TPR) domain of Pex5, the PTS1 receptor, than the simple C-terminal 
tripeptide SKL originally described (Brocard et al., 1994; Neuberger et al., 2004; Neuberger 
et al., 2003, McCollum et al., 1993, reviewed by Brocard and Hartig, 2006).  
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1.2 The lifecycle of a peroxisome 
 
The lifecycle of a peroxisome is a multi-step process which involves 1) import of membranes 
and membrane proteins (PMPs) via the ER, 2) import of matrix proteins, 3) growth and 
subsequent elongation, 4) fission and 5) degradation and inheritance.  
 
1.2.1 Protein import 
 
The peroxisomal matrix protein import can be divided into four steps: i) cargo recognition by 
a cytosolic receptor (Pex5 and Pex7 for PTS1 and PTS2, respectively), ii) interaction with the 
docking machinery, iii) translocation and iv) recycling of the receptor (reviewed by Platta and 
Erdmann, 2007). While Pex5 directly interacts with Pex14, Pex7 needs an additional adaptor 
(Pex18/Pex21 in yeast, the splice variant Pex5L in mammalians) to interact with Pex14 
(Figure 2, Albertini et al., 1997, Brocard et al., 1997; Einwachter et al., 2001, Williams et al., 
2005, Niederhoff et al., 2005).  
 
   Figure 2: PTS1-dependent protein import in the peroxisomal matrix; 
   from Platta and Erdmann, 2007 
 
Little is known about the import of peroxisome membrane proteins (PMPs). There exist two 
classes of PMPs, one is believed to be directly targeted and inserted in the peroxisomal 
membrane (Class I), the other being routed via the ER to its final destination (Class II, Fang et 
al., 2004). The import machinery is thought to consist of Pex16, Pex3 and Pex19, the latter 
may perform a chaperone-like activity (Hettema et al., 2000, Purdue and Lazarow, 1995, 
South and Gould, 1999). Moreover, the identification of a targeting sequence for the 
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peroxisomal membrane (mPTS) has been an issue (Dyer et al., 1996, Honsho and Fujiki, 
2001, Wang et al., 2001, Pause et al., 2000, Rottensteiner et al., 2004). Different consensus 
sequences and domains were shown to be necessary for correct import. It is believed that not 
only a short targeting sequence but at least one transmembrane domain (TMD) contribute to a 
fully functional mPTS. This implies that the mPTSs greatly vary between PMPs (reviewed by 
Brown and Baker, 2003).  
 
 
1.2.2 Biogenesis and Proliferation 
 
There exist two ways for the biogenesis of organelles: i) autonomous replication with the 
ability to proliferate by fission of preexisting organelles (ER, mitochondria, chloroplasts) or 
ii) non-autonomous biogenesis (lysosomes, endosomes). The origin of peroxisomes has long 
been a matter of discussion. An endosymbiotic theory was proposed (De Duve, 1969). 
However, evidence pointed at a model by which peroxisomes proliferate by fission of 
preexisting organelles. The finding that peroxisomal membrane proteins are synthesized on 
free polysomes (Lazarow and Fujiki, 1985) supported this model. Additionally, genetic 
screens, mostly in the yeast S. cerevisiae, led to the identification of genes coding for 
proteins, which are components of the division machinery, with Pex11 as the most abundant 
protein. Disruption of Pex11 leads to few and enlarged peroxisomes in yeast (Erdmann and 
Blobel, 1995). In this organism it is believed that Pex11 drives the elongation of the organelle 
in combination with Pex25 and Pex27. Recent evidence suggests that Pex25 may recruit the 
GTPase Rho1 to control actin assembly at the peroxisomal membrane. Marelli et al. used a 
novel approach by combining classical subcellular fractionation with large-scale quantitative 
mass spectrometry to identify peroxisomal proteins, among those Rho1 was identified. GST-
immobilized Rho1 was shown to interact with Pex25 in an in vitro binding assay (Marelli et 
al., 2004).  
Among the proteins involved in the peroxisomal fission event Vps1, Dnm1 and Fis1, 
are also known from mitochondrial fission. Fis1 recruits Dnm1, a dynamin-related protein, to 
the peroxisomal membrane (Kuravi et al., 2006). There might exist an adaptor protein 
involved similar to the proteins Mdv1 or Caf4 found in mitochondria (Zhang and Chan, 2007) 
In mammalian cells, a similar mechanism has been described: The C-terminal tail-anchored 
membrane protein, Fis1, seems to be recruited by HsPex11β to the peroxisomal membrane, 
which then interacts with the dynamin-like protein Dlp1, the orthologue of Dnm1 (Li and 
Gould, 2003, Koch et al., 2004). Even ternary complexes comprising Fis1, Dlp1 and 
1. INTRODUCTION 
 6 
HsPex11β were detected in a coimmunoprecipitation assay (Kobayashi et al., 2007). A lately 
discovered membrane protein, Mff, plays a role in mitochondrial and peroxisomal fission, but 
coimmunoprecipitation experiments revealed that Mff belongs to a different complex than 
Fis1 implying a more distinct role of Mff in the proliferation machinery (Gandre-Babbe and 
van der Bliek, 2008). After fission peroxisomes tend to remain clustered, the dissociation 
seems to require the function of the proteins Pex28 and Pex29 (Vizeacoumar et al., 2003). 
The close correlation between the mitochondrial and peroxisomal fission process is evident. 
Additionally, a cargo-selected vesicular transport from mitochondria to peroxisomes 
strengthens the interplay between these two organelles (Neuspiel et al., 2008). 
The model of autonomous proliferation has become controversial with the finding that 
mutant cells lacking functional peroxisomes could develop peroxisomes de novo upon 
insertion of the missing gene (Kragt et al., 2005, Haan et al., 2006). Several studies on Pex3 
showed the possibility of a de novo synthesis of peroxisomes: In Yarrowia lipolytica 
unsynchronized biogenesis happens in temperature-sensitive pex3-mutants. These new, 
immature peroxisomes associate closely with the ER (Bascom et al., 2003). A further proof 
that Pex3 plays a critical role in the early steps of biogenesis was shown in Hansenula 
polymorpha. The synthesis of the N-terminal 50 amino acids of Pex3 in pex3-mutant cells 
resulted in the formation of vesicular structures containing Pex14, which could be released 
upon reintroduction of full length Pex3. Here, the nucleus seems to donate the membrane 
compartment (Veenhuis et al., 1996). Similar experiments using a truncated version of Pex3 
in S. cerevisiae led to the conclusion that the ER may represent the donor rub for peroxisome 
biogenesis (Tam et al., 2005). In vivo experiments in S. cerevisiae underlined these findings 
(Hoepfner et al., 2005). Interestingly, already decades ago electron microscopy images from 
Novikoff et al. showed an association between the ER and peroxisomal structures (Novikoff 
and Novikoff, 1972). Moreover, high resolution immuno-electronmicroscopy and electron 
tomography led to the suggestion that the ER membrane was the origin of the newly 
synthesized peroxisomes (Tabak et al., 2003). 
In contrast to fungi, in mammalian or in plant cells, Pex3 could not be detected  alone in 
association with the ER (Fang et al., 2004, Hunt and Trelease, 2004). Indeed, these cells seem 
to require the presence of the protein, Pex16, which then works in concert with Pex3 and 
Pex19 (Kim et al., 2006). Additionally, the involvement of Arf and coatamer in the process of 
peroxisome proliferation propose a retrograde transport from the peroxisomes to the ER in 
mammalian cells (Lay et al., 2006). Moreover, the observation of protein translocation from 
peroxisomes to the ER makes this retrograde transport also likely in plant and trypanosomes 
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(McCartney et al., 2005, Subramanya and Mensa-Wilmot, 2006). Today peroxisomes are 
being considered to derive from the ER and to have the ability to proliferate and divide upon 
induction (Figure 3). 
 
 
Figure 3: Division and proliferation of peroxisomes - an overview, designed  
by Brocard C., 2007 (unpublished data) 
 
1.2.3 Peroxisomal induction 
 
Peroxisomes are very adaptable organelles. In order to quickly adapt their manifold enzymes, 
they must react to various stimuli. Peroxisomes proliferate upon stimulation by herbicides, 
xenobiotics, ozone or during senescence (Pastori and Del Rio, 1997, Lazarow and Fujiki, 
1985). The alpha form of the peroxisome proliferator activator receptor (PPARα) plays a 
critical role in regulating genes for the lipid homeostasis (Green, 1995). It binds to the 
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peroxisome proliferator response element (PPRE), which then activates the transcription of  
several genes (Lemberger et al., 1996). PPARα is stimulated by many ligands such as 
hypolipidemic drugs (Issemann and Green, 1990). While some studies showed that 
HsPex11α- expression is affected by PPARα (Shimizu et al., 2004), others postulated that 
this peroxin is dispensable for PPARα-mediated proliferation. However, HsPex11α 
expression is affected upon sodium 4-phenylbutyrate induced proliferation (Li et al., 2002a). 
It has recently been shown that in plant cells even light induces peroxisome proliferation 
through phytochrome A, HY5 homologue and finally AtPex11b (Desai and Hu, 2008).  
In yeast, peroxisome proliferation is induced by the presence of fatty acids (e.g. oleic acid) in 
the culture medium (Rottensteiner et al., 2003, Tam et al., 2003). In S. cerevisiae an oleate-
responsive-element (ORE) in the promoter sequence of oleate-inducible genes binds the 
transcription factor dimer Oaf1/Pip2 (Rottensteiner et al., 1997). 
 
1.2.4 Pexophagy and inheritance 
 
The rapid reaction of peroxisomes on cellular demands requires a robust turnover machinery. 
The removal of peroxisomes is similar to autophagy, and was called pexophagy (Yokota, 
1993, Sakai et al., 2006). Today, two distinct pathways i) the macropexophagy and ii) the 
micropexophagy contribute to peroxisome homeostasis. In micropexophagy, the lysosome 
engulfs the peroxisome, whereas in macropexophagy individual peroxisomes are sequestered 
by multiple membrane layers, which then fuse with lysosomes (Sakai et al., 2006). 
Not only biogenesis and proliferation, but also inheritance of peroxisomes to daughter cells is 
critical in order to maintain peroxisomal function. In budding yeast, Inp2 an integral 
membrane protein of peroxisomes, works as the receptor for Myo2, a motor protein for actin, 
and ensures the transport along the actin filaments towards the bud (Fagarasanu et al., 2006). 
On the opposite, the protein Inp1 serves to retain the peroxisomes due to its strong intrinsic 
affinity for the cell cortex (Fagarasanu et al., 2005). The delicate interplay between these two 
proteins is responsible for the correct partitioning of peroxisomes between the mother and the 
daughter cell during cell division.  
1. INTRODUCTION 
 9 
1.3 Proteins of the PEX11- family 
 
Because all Pex11 proteins of higher organisms are orthologues of ScPex11, the focus of the 
introduction will concentrate on the yeast Pex11 family first. 
 
 
1.3.1 Yeast PEX11 proteins 
 
ScPex11 (formerly Pmp27) is the most abundant peroxin and has always been cited in context 
with proliferation (Marshall et al., 1995). The implication of this protein to peroxisome 
proliferation was first suggested by Erdmann et al.: Yeasts lacking the PEX11 gene were still 
able to grow on glucose or on ethanol, but failed to grow on oleate as the sole carbon source. 
Microscopy revealed that these yeast cells contain only few, but giant peroxisomes (Erdmann 
and Blobel, 1995). Soon after, experiments on the localization, orientation and protein 
interaction of ScPex11 suggested that ScPex11 localized on the inner surface of the 
membrane and that it may form homodimers. The monomeric form was proposed to be the 
active one, whereas dimer formation was anticipated to inhibit further division since 
immature peroxisomes have a lower dimer to monomer ratio than mature ones (Marshall et 
al., 1996). The finding that ScPex11 is required for β-oxidation of medium chain fatty acids 
led to the hypothesis that proliferation is regulated metabolically (van Roermund et al., 2000).  
Later, the identification and analysis of two ScPex11 related proteins, ScPex25 and ScPex27 
(Rottensteiner et al., 2003; Smith et al., 2002; Tam et al., 2003) complicated this simple view 
of peroxisome proliferation. Interestingly, growth on oleate of pex25pex27-mutant yeast cells 
was not inhibited. Additional deletion of ScPex11 completely abolished growth but it could 
be restored by overexpression of ScPex25 only. Yeast two hybrid assays confirmed the 
known interaction of ScPex11 with itself and further showed that ScPex25 and ScPex27 can 
interact with each other and themselves. 
Although ScPex11, ScPex25 and ScPex27 amino acids sequences are quite similar (~10% 
identity and ~18% similarity), ScPex25 and ScPex27 exhibit an extended N-terminus as 
compared to ScPex11 and are both peripheral membrane proteins. ScPex25 is thought to 
recruit Rho1 to the peroxisomal membrane (Marelli et al., 2004).  
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1.3.2 Plant PEX11 proteins 
 
Five orthologues of ScPex11 have been identified in the plant Arabidopsis thaliana, 
AtPex11a to e (or AtPex11-3,-4,-1,-5,-2). No obvious homologues sequences of ScPex25/27 
or ScPex28-32 were reported, so far. The Pex11 proteins can be divided into three 
phylogenetically distinct subfamilies AtPex11-3, AtPex11-4 and AtPex11-1,-2,-5, further 
divided into two classes. Class I AtPex11 are highly similar (>90%, AtPex11-1,-2,-5), class II 
AtPex11 are more divergent (~50% similarity, AtPex11-3,-4). All localize to peroxisomes and 
induce proliferation. Only AtPex11-4 is not an integral membrane protein. AtPex11-3, -1 and 
-2 are constitutively expressed with AtPex11-1 and -2 having the highest expression levels, 
whereas AtPex11-4 seem to be rather upregulated in senescent tissue. Moreover, AtPex11-4 is 
thought to play a role in leaf peroxisome photorespiration in young seedlings (Lingard and 
Trelease, 2006, Orth et al., 2007). 
 
 
Figure 4: Neighbor-Joining Tree of PEX11 Protein Sequences. 
Numbers at the nodes are bootstrap values from 1000 trials; 
An,Aspergillus nidulans; At, Arabidopsis thaliana; Cf, Canis 
familiaris; Hs, Homo sapiens; Le, Solanum lycopersicum 
(formerly Lycopersicon esculentum); Nc, Neurospora crassa; 
Os, Oryza sativa; Sc, Saccharomyces cerevisiae; Tn, Tetraodon 
nigroviridis; Yl, Yarrowia lipolytica; from Orth et al., 2007 
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Additionally, the orientation of myc-tagged versions of the five AtPex11 proteins was 
investigated in A. thaliana. Both, N- and C-termini of AtPex11-1,2,4 and -5 were facing the 
cytosol, just AtPex11-3 exposed its C-terminus to the peroxisomal matrix (Lingard and 
Trelease, 2006). Recent data showed a cooperative role for AtPex11-1,-5 and -2 during the 
G2 phase of the cell cycle. Similar to the findings in mammalians and yeast, Fis1b is recruited 
to the peroxisomal membrane by oligomeric AtPex11 proteins, which then indirectly bind 
Drp3a to initiate the fission process (Lingard et al., 2008). 
1.3.3 Human PEX11 proteins 
 
Three PEX11 genes have been identified in mammalian cells, coding for HsPex11α 
(HsPex11A), HsPex11β (HsPex11B) and HsPex11γ (HsPex11C), respectively (Abe and 
Fujiki, 1998; Abe et al., 1998; Tanaka et al., 2003). Phylogenetic analysis revealed that 
HsPex11α is more closely related to HsPex11β than both are to HsPex11γ, though 
interestingly HsPex11α is more similar to the Pex11 protein of Canis familiaris (Figure 4).  
This tree suggests that all known Pex11 proteins form a monophyletic group. HsPex11α is 11 
amino acids longer than ScPex11 with 25% identity, it contains two hydrophobic regions as 
well as a dilysine motif at its C-terminus. HsPex11β has 12 amino acids more than HsPex11α 
and shares 40% identity with HsPex11α and 20% with ScPex11.  
 
 
Figure 5: Amino acid sequence alignment of human PEX11α , PEX11β, nd 
Pex11γ. Sequences were aligned by the CLUSTAL W method. Putative 
transmembrane spanning segments are overlined; from Tanaka et al., 2002 
 
Between these human Pex11 proteins a higher level of identity was found in the C- terminal 
region (57% compared to 43%). HsPex11β also contains two hydrophobic domains and a 
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RxKx motif, similar to the KxKxx motif of HsPex11α. Both proteins have a potential N-
glycosylation site (HsPex11α at Asn9 and HsPex11β at Asn134). HsPex11γ is 241 amino 
acids long has two putative transmembrane segments and shows 22% and 23% amino acid 
identity to HsPex11α and HsPex11β, respectively (Figure 5). 
In contrast to HsPex11α both, HsPex11β and HsPex11γ are constitutively expressed and not 
inducible by fibrate (Abe et al., 1998). 
 
1.3.3.1 The human Pex11α 
 
The membrane protein HsPex11α exposes both N- and C-terminal ends to the cytosol as 
revealed by immunofluorescence microscopy experiments. Mutations either changing the 
dilysine motif (243KLKLLL) or eliminating the potential N-glycosylation site (9ND) did 
not disturb the correct localization to peroxisomes. Moreover, the 9ND mutation did not 
change the electrophoretic mobility implying that human HsPex11α was not glycosylated 
under the conditions tested (in CHO cells, Abe et al., 1998).  
An interaction between HsPex11α, Arf and coatomer was reported, suggesting the 
recruitment of the coatomer by HsPex11α (Passreiter et al., 1998). However, it was later 
demonstrated, that the binding to the coatomer is not required for the function of HsPex11α in 
proliferation (Maier et al., 2000). Maybe the mentioned KXKXX motif is responsible for an 
involvement of the coatomer only under certain circumstances. 
No complementation group of peroxisomal deficiencies exist in which HsPex11α is mutated 
(Abe et al., 1998). Interestingly, a Pex11α-/- mouse has no significant physiological changes 
compared to a Pex11α+/+ mouse. Moreover, normal peroxisome abundance was detected, 
though a tendency to form peroxisome clusters was observed. The general peroxisome 
metabolism was unaffected. The highest expression level was measured in the liver. Although 
HsPex11α is strongly inducible by 4-PBA and fibrates, it was described to be dispensable for 
PPARα-mediated peroxisome proliferation (Li et al., 2002a).  
 
1.3.3.2 The human Pex11β 
 
Peroxisomal localization of HsPex11β, another membrane protein was proven by 
immunofluorescence microscopy. Northern blot analysis revealed that this protein is 
constitutively expressed and could not be induced by clofibrate treatment (Abe and Fujiki, 
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1998). Pex11β-/- mice displayed neonatal lethality, hypotonia, reminiscent of the human 
Zellweger syndrome and intrauterine growth retardation (Li et al., 2002b). Additionally, 
defects in the neuronal migration in coronar sections were observed in these Pex11β null 
mice. Among the other symptoms were enhanced neuronal apoptosis, delayed renal 
development and calvarium ossification. However, the peroxisomal protein import and 
mitochondrial structure were not affected. Likewise, VLCFA accumulation was not the 
reason for the neuronal abnormalities.  
Investigations of double homozygous mice Pex11α-/-Pex11β-/- revealed mostly the same 
phenotypes as homozygous Pex11β-/- mice. Speaking of peroxisome abundance, both the 
single and the double mutant had approximately half the numbers of peroxisomes as the wild 
type control mice (Li et al., 2002a).  
Biochemical analysis revealed that the C-terminal region of HsPex11β is essential for a direct 
interaction with Fis1, whereas the N-terminus is indispensable for homo-oligomerization and 
function. Overexpression of HsPex11β in CHO-K1 cells led to a significant increase in the 
number of peroxisomes. Kobayashi et al. isolated ternary complexes comprising of 
HsPex11β, Fis1 and Dlp1 by means of coimmunoprecipitation after chemical crosslinking 
(Kobayashi et al., 2007). No direct interaction of HsPex11β with Dlp1 was detected, 
furthermore it could not be shown in association with HsPex11α (Li and Gould, 2003).  
Moreover, speculations on a regulation of Pex11β-mediated proliferation by the β-oxidation 
fell off as Zellweger cells though lacking all peroxisomal metabolic function still contain 
peroxisomes. In these cells peroxisome abundance was 30 times higher than in wild type cells 
after transfection with a plasmid coding for HsPex11βmyc. This demonstrates  that these 
peroxisomal membrane remnants are able to proliferate (Li and Gould, 2002).  
 
1.3.3.3 The human Pex11γ 
 
This membrane protein exposes both termini to the cytosol, comparable to HsPex11α. Similar 
to HsPex11β, it is not inducible by fibrates, but it is constitutively expressed (Tanaka et al., 
2003). Indeed, it was reported that the overexpression of HsPex11γ does not induce 
peroxisomes proliferation, but produces large and clustered peroxisomes (Li et al., 2002a). So 
far, only speculations about its function remain, since not much biochemical analysis of this 
protein is available, yet. Therefore, it represents a very good target for further investigations 
on the molecular mechanisms of peroxisome proliferation.  
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2 Aim of the Thesis 
 
The peroxisomal biogenesis machinery executes an important process, as deficiencies within 
this mechanism are lethal for humans. The Pex11 protein family plays a central role in the 
proliferation of peroxisomes – in yeast, plant and human tissue. 
The project, this thesis is embedded in, aims to elucidate the function of the various Pex11 
families in yeast, plant and human cells. We work on the analysis of the different and the 
common elements of the Pex11 proteins and compare these within three kingdoms. This will 
help to understand the molecular role of Pex11.  
This thesis focuses on the analysis of the dynamics of the peroxisomal proliferation in 
human cells. To address the issue of membrane dynamics we raised the question, whether any 
correlation exists between the number of peroxisomes and area of peroxisomal membranes. 
Furthermore, we aim to understand the regulation of the different human Pex11 proteins as 
well as the importance of the domains of these proteins. A key goal to specifically analyze the 
molecular function of a protein lies in the identification of interaction partners and the 
characterization of a potential assembly into complexes. This requires a suitable tag for 
labeling the proteins of interest.  
In order to achieve our aims, we investigated the localization and function of all Pex11 
proteins in human cells at various time points. To present statistically relevant data, we 
counted the number and area of peroxisomes. We analyzed the protein expression of mutated 
versions of Pex11, where either mutations on two putative phosphorylation sites were 
introduced or whole domains were truncated. 
Additionally, we established a novel technique for labeling our proteins of interest. This tag, 
called SNAP tag or human alkylguaninetransferase (hAGT) covalently binds its substrate. We 
modified this tag to introduce a tobacco etch virus (TEV) protease site in order to release our 
protein of interest from the tag. Consequently, this enables to use this tag conveniently for 
both, live cell imaging and immunoprecipitation. These analyses all require stably transfected 
cell lines, which were generated during the work of the thesis.  
Live cell imaging will enlighten the role of Pex11 in terms of the peroxisomal proliferation 
dynamics. The identification of interaction partners by means of coimmunoprecipitation and 
complex isolation of membrane proteins will certainly provide new insights. As no human 
cell line mutated in the genes coding for any Pex11 is known, we plan to compare the 
overexpression phenotype to the knock-down phenotype through siRNA experiments.  
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The deep scrutiny of the human Pex11 family will bring forth new aspects of complex 
isolation, organelle proliferation and membrane dynamics. 
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3 Results 
3.1 Ectopic expression of Yeast and Plant Pex11 proteins lead 
to peroxisome proliferation in human cells 
 
Understanding the evolution of Pex11 will help to pinpoint its function. The Pex11 protein 
families in human and plant cells were originally found as orthologues of ScPex11 (Abe et al., 
1998, Lingard and Trelease, 2006). We sought to clarify whether the function of the various 
Pex11 proteins are conserved throughout three kingdoms. The localization of yeast or plant 
Pex11 to the human peroxisomal membrane would give a first hint towards a conserved 
function of the investigated proteins. Changes in peroxisomal number, size or morphology 
serve as read out to scrutinize the molecular function of Pex11.  
We performed colocalization experiments to address this question. In order to analyze 
the wild-type phenotype, we cotransfected plasmids encoding two peroxisomal marker 
proteins in human embryonic kidney cells (HEK293T), a red fluorescent protein appended 
with a PTS1 (mCherry-SKL, Shaner et al., 2004) and Sterol carrier protein 2, a known 
peroxisomal protein carrying a PTS1 appended with GFP at its N-terminus (GFP-Scp2, 
Frolov et al., 1996). We observed complete colocalization of these two proteins (Figure 6D). 
Herewith, the size, abundance and morphology of peroxisomes did not change compared to 
singly transfected cells. Significantly, many round-shaped peroxisomes were present 
throughout the whole cell. Most of those were well separated, though some seemed to be 
connected, an artifact due to the projection in the z- dimension (see section 3.2 & appendix 
for details). These findings confirmed our experimental setup. 
To compare all known Pex11 proteins, we first evaluated the effect of the overexpression of 
human Pex11α, β and γ on peroxisome number and size. We used N-terminally GFP- tagged 
versions of each Pex11 protein under the control of the cytomegalovirus (CMV) promoter 
(see appendix for detailed information). Our results show that all, GFP-HsPex11α, β and γ 
fusion proteins colocalized with the peroxisomal marker mCherry-SKL. Furthermore, cells 
overexpressing GFP-HsPex11α presented significantly more small peroxisomes than wild 
type cells (Figure 6A). Even more pronounced was the effect of GFP-HsPex11β 
overexpression (Figure 6B). In both experiments, the cells had at least doubled the number of 
peroxisomes as compared to HEK293T cells transfected with mCherry-SKL only. In contrast, 
in about 80% of the cells overexpression of GFP-HsPex11γ led to tubule-formation and 
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clustering of peroxisomes (see Figure 6C). This however was not accompanied by an increase 
in the peroxisomal number. 
 
 
Figure 6: Ectopic overexpression of the three human Pex11 proteins in HEK293T cells 24h after 
transfection, (A) GFP-HsPex11α induces proliferation, (B) GFP-HsPex11β strongly promotes division, 
(C) GFP-HsPex11γ leads to formation of large and clustered peroxisomes, (D) wild type peroxisomes 
with GFP-Scp2; red channel (A-D): mCherry-SKL, images are projected stacks; bar: 10µm 
 
Indeed, it seems as if with an excess of GFP-HsPex11γ the peroxisomes formed clusters, but 
the final fission and separation steps in proliferation are hampered. In cells that did not 
contain clustered peroxisomes, those present looked like in wild-types (see Figure 19C, 22h). 
Taken together, our experiment show that all GFP-tagged Pex11 proteins used are efficiently 
targeted to peroxisomes and that each of these proteins may have a different effect on 
peroxisome proliferation.  
The overexpression of yeast and plant GFP-Pex11 proteins revealed some similarities 
compared to the overexpression of the human GFP-Pex11 proteins. Overexpression of GFP-
ScPex11 clearly led to far more peroxisomes per cell than the expression of proteins of the 
Pex11-family from any other organism analyzed (Figure 7). In contrast, overexpression of the 
yeast GFP-ScPex25 led to enlarged and clustered peroxisomes, which resembles the 
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observations with GFP-HsPex11γ. However, each cluster formed appeared to be smaller than 
those visualized through overexpression of the human GFP-HsPex11γ. Overall, in presence of 
GFP-ScPex25 individual cells contain slightly fewer peroxisomes as compared to cells 
transfected with the mCherry-SKL only. 
 
 
Figure 7: Ectopic overexpression of the yeast Pex11 proteins in HEK293T cells 24h post transfection; 
(A) GFP-ScPex11 strongly induces proliferation, (B) GFP-ScPex25 forms clustered, larger peroxisomes, 
(C) wild type peroxisomes with GFP-Scp2; red channel (A-C): mCherry-SKL, images are projected 
stacks; bar: 10µm 
 
 
All plant GFP-tagged Pex11 proteins localized to peroxisomes, and in some cases 
peroxisomes appeared clustered as illustrated through overexpression of GFP-AtPex11-1 to a 
minor part and GFP-AtPex11-2 to a major part (Figure 8). Noteworthy, cytosolic 
accumulation of the peroxisomal matrix marker mCherry-SKL seemed to correlate with the 
overexpression of GFP-AtPex11-4 and GFP-AtPex11-5. Peroxisome clustering has 
previously been reported in plant cells overexpressing GFP-AtPex11-1,-2 and -5 (Orth et al., 
2007). The same group reported the induction of proliferation without clustering for GFP-
AtPex11-3 and -4. In our experiments, we cannot confirm a clustering for GFP-AtPex11-5, 
since the overexpression of GFP-AtPex11-5 led to so many peroxisomes that it is nearly 
impossible to distinguish between single separated and clustered peroxisomes.  
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Figure 8: Ectopic overexpression of the plant Pex11 protein family in HEK293T 24h post transfection; 
(A) GFP-AtPex11-1 partially and (B) GFP-AtPex11-2 induces the formation of enlarged and clustered 
peroxisomes, (C) GFP-AtPex11-3 and (D) GFP-AtPex11-4 induce proliferation, (E) GFP-AtPex11-5 
slightly promotes fission of peroxisomes, (F) wild type peroxisomes; red channel (A-F): mCherry-SKL; 
images are projected stacks, bar: 10µm 
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Cells overexpressing GFP-AtPex11-2 presented a dramatically reduced number of 
peroxisomes. The overexpression of GFP-AtPex11-3 and -4 had only slight effects on the 
peroxisome number. Still, an increase in the peroxisome abundance was detected.  In contrast, 
overexpression of GFP-AtPex11-4 led to the induction of tubule-formation or elongation of 
peroxisomes (arrow in Figure 8). A detailed analysis will be presented in section 3.2. 
 
3.1.1 A functional relationship between yeast, plant and human 
Pex11 proteins 
 
The colocalization of all Pex11 fusion proteins expressed with the peroxisomal matrix marker 
mCherry-SKL demonstrates that they all localize to peroxisomes. Moreover, the various 
effects observed on peroxisome number and size suggest that they all may be functional in 
human cells. At least one protein from each model organism showed an induction of tubules, 
clusters or, generally enlarged peroxisomes (e.g. GFP-HsPex11γ, GFP-ScPex25, GFP-
AtPex11-2). This could represent an early step in the proliferation process. Indeed, it has been 
reported in the yeast S. cerevisiae that peroxisomes tend to remain associated after the fission 
event. Their separation requires the presence of the proteins ScPex28 and 29 (Vizeacoumar et 
al., 2003). The fact that this happens with the Pex11 proteins from each studied kingdom 
might suggest a conserved mechanism for peroxisome proliferation or at least a conserved 
function for proteins of the Pex11-family.  
Our study demonstrates that all proteins of the Pex11-family have an effect on peroxisome 
number. However, despite the fact that the cells remained viable more than 50 hours after 
transfection, it remains to be demonstrated whether the peroxisomes are fully functional in 
cells overexpressing Pex11 proteins with regard to protein import or oxidative stress response. 
A potential redox-sensitive homodimerization of ScPex11 had been reported which could 
negatively influence the regulation of ScPex11 function (Marshall et al., 1996). Therefore, it 
will be extremely informative to test whether the overexpression of Pex11 proteins in human 
cells confronted with oxidative stress leads to similar observations on peroxisome 
proliferation.  
Overall, overexpression of HsPex11α led to more, smaller peroxisomes, but to a 
smaller extent than that of HsPex11β. In contrast, HsPex11γ overexpression led to the 
formation of large clusters. Notably, these phenotypes have already been reported. HsPex11α 
and β were overexpressed in CHO-K1 and mouse cells presenting similar effects. Only 
HsPex11γ was investigated in human fibroblasts (Li et al., 2002a). Interestingly, all yeast and 
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plant fusion proteins localize to peroxisomes. This colocalization cannot be explained with 
the presence of a simple PTS, since all Pex11 are membrane proteins exhibiting an mPTS. As 
reported, the mPTS is not fully understood, yet (Brown and Baker, 2003). However, at least 
one transmembrane is required for correct localization. This excludes random artifacts, that 
just any protein such as for instance soluble proteins could be inserted by chance.  
The fact that overexpression of Pex11 proteins leads to morphological changes of 
peroxisomes in several ways suggests that they are functional. This is especially fascinating 
for the plant Pex11 proteins. Ectopic expression of GFP-AtPex11-2 resulted in the formation 
of larger and clustered peroxisomes, which are however smaller than those observed upon 
overexpression of GFP-HsPex11γ or GFP-ScPex25. Expression of GFP-AtPex11-1 in human 
cells resulted in the formation of only few clustered peroxisomes. Apparently, the effect of 
GFP-ScPex25 expression in human cells is very similar to that of GFP-HsPex11γ (Figure 6C 
& Figure 7B). Still, their physiological role may be more distinct since the phylogenetic 
analysis of the genes coding for HsPex11γ and ScPex25 reveals only a weak correlation 
(Figure 4, Orth et al., 2007). They share the same origin; however, several rounds of 
divergence could have led to different tasks within the peroxisomal proliferation machinery. 
The amino acid sequences of AtPex11-1 and -2 are even less similar than those of HsPex11γ 
and ScPex25. However, these bioinformatics data are always based on mathematical 
algorithms controlled by manually set parameters, which tends to be error-prone. 
 
3.2 3D reconstruction of peroxisomes 
 
In the colocalization experiments, we observed several kinds of peroxisomes, enlarged and 
clustered as well as smaller ones. However, to better perceive the variations of peroxisome 
number and size attributed to the expression of each Pex11 protein we sought to analyze the 
three dimensional structure of peroxisomes in transfected cells. The projection of a z-stack 
may produce artifacts, vesicles seem to adhere to each other, but are well separated in the 
third dimension. Moreover, the colocalization can be judged in three dimensions as well.  
We deconvolved a representative z-stack (d=0.5µm) with a calculated point-spread 
function (PSF). The deconvolved stack was then rendered using VolumeJ (Abramoff and 
Viergever, 2002, see Methods section for details) and turned around the y-axis. This results in 
a plastic view of the structures, while the shading gives an impression of the third dimension.  
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Figure 9 shows a region of a cell transfected with mCherry-SKL and GFP-Scp2 our wild-type 
phenotype. Note, that even in such a cell some peroxisomes are elongated, which could be a 
hint for ongoing proliferation. 
 
Figure 9: 3D reconstruction of a selected area of 
HEK293T cells overexpressing mCherry-SKL and GFP-
Scp2; image stacks (d=0.5µm) were deconvolved and 
rendered resulting in a 3D view revealing the fine-
structures of peroxisomes; bar: 10µm 
 
Figure 10 shows the three human Pex11 fusion proteins in HEK293T cells. While some of the 
peroxisomes are always interconnected, most of them are separated. Only GFP-HsPex11γ 
shows both, enlarged (arrow in Figure 10) and clustered peroxisomes.  
 
 
Figure 10: 3D reconstruction of a selected area of HEK293T cells overexpressing human (A) GFP-
Pex11α, (B) GFP-Pex11β and (C) GFP-Pex11γ  N-terminally GFP tagged; image stacks (d=0.5µm) were 
deconvolved and rendered resulting in a 3D view revealing the fine-structures of peroxisomes; bar: 
10µm 
 
The fine-structures in the clusters suggest that indeed more than one peroxisome is present. 
Expression of the yeast constructs showed similar structures (Figure 11). GFP-ScPex11 
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resulted in an increase in peroxisome interconnection, which seems to correlate with 
proliferation (see Figure 7). In Figure 11B, the strong background fluorescence produced by 
the marker protein mCherry-SKL still does not disturb the 3D view.  
 
 
Figure 11: 3D reconstruction of a selected area of HEK293T cells overexpressing (A) GFP-ScPex11, (B) 
GFP-ScPex25 N-terminally GFP tagged; image stacks (d=0.5µm) were deconvolved and rendered 
resulting in a 3D view revealing the fine-structures of peroxisomes; bar: 10µm  
 
The 3D reconstructions of the overexpressed GFP-AtPex11-1 to -5 correlate with the 
colocalization images (Figure 8, Figure 12). Upon ectopic overexpression of GFP-AtPex11-2, 
human cells contained fewer peroxisomes; especially the clusters are smaller and seem to be 
more compact. When GFP-AtPex11-3 was overexpressed, a reported inductor of proliferation 
(Orth et al., 2007), many small peroxisomes were produced that were well separated.  
GFP-AtPex11-4 might act as proliferator, since its expression in human cells resulted in the 
appearance of more elongated peroxisomes as compared to GFP-AtPex11-3, but some are 
interconnected and form tubules (arrow in Figure 12D). These “sausage-like” structures were 
reported in yeast cells deleted for a protein of the fission machinery (Schauss et al., 2006, 
Kuravi et al., 2006). Additionally, Koch et al. have reported similar observations in COS-cells 
knocked down by siRNA for Dlp1, a protein involved in the mitochondrial and peroxisomal 
fission process (Koch et al., 2004). We propose that these structures represent ongoing 
proliferation. Since those “sausage-like” structures are not present throughout the whole cell, 
is it unlikely that these observations can be attributed to a defect in the peroxisomal fission 
process. GFP-AtPex11-5 seems to be the most potent proliferator of all plant Pex11 proteins 
in HEK293T cells. The high number of peroxisomes combined with only little distance in 
between makes the deconvolution and 3D rendering procedure difficult to achieve properly. 
However, the peroxisomes seem to remain separated and appear clustered only due to their 
high density. 
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Figure 12: 3D reconstruction of a selected area of HEK293T cells overexpressing (A) GFP-AtPex11-1, 
(B) GFP-AtPex11-2, (C) GFP-AtPex11-3, (D) GFP-AtPex11-4 and (E) GFP-AtPex11-5; image stacks 
(d=0.5µm) were deconvolved and rendered resulting in a 3D view revealing the fine-structures of 
peroxisomes; bar: 10µm 
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3.3 Statistical analysis of the influence of Pex11 proteins 
 
The observation of confocal laser scanning microscopy (CLSM) images is always 
accompanied by personal bias, which is usually moderated by evaluating the reproducibility 
and imaging many coverslips of different experiments. Representative image stacks are 
shown in Figure 6-Figure 8.  
A statistical analysis therefore provides a more profound basis for the quantitative evaluation 
of microscopy data.  
We used and expanded established counting techniques (Kim et al., 2006). Briefly, we 
collected images of at least 50 cells for the expression of each Pex11 protein 22 hours after 
transfection. All images were taken in the widest focal plane of a cell containing the most 
peroxisomes. These images were handled as described (see Methods for details). Images were 
filtered, converted to 8-bit and a threshold was applied to highlight the peroxisomal 
fluorescence. Then, each cell was encircled manually and the peroxisomes were counted by 
using the Particle Analysis package of ImageJ1. A z-stack would certainly enable us to 
consider all peroxisomes of one cell, but the problem of spatial discrimination would emerge. 
 
  category I category II category III category IV 
diameter [µm] 0-0.35 0.36-0.66 0.67-0.95 0.96-10 
area [µm2] 0-0.1 0.11-0.34 0.35-0.71 0.72-78,54 
 
Table 2: four categories of peroxisomal size: category II represents the normal peroxisome, category I the 
small ones, whereas enlarged peroxisomes are found in categories III and IV  
 
Additionally, we measured the total area covered by all peroxisomes of each category. 
Certainly, the acquisition of large amount of data may lead to a strong bias. To avoid this we 
sought to compare relative trends for each sample. We divided the peroxisomes into four 
categories with increasing diameter (Table 2). The normal-sized peroxisomes are found in 
category II. Categories I and III represent boundary regions since the size of peroxisomes 
varies even in wild type cells. Nevertheless, fission of peroxisomes into smaller ones would 
shift the majority of the peroxisomes from category II to I. Category IV encloses all bigger, 
clustered or enlarged peroxisomes, though some might be found in category III as well.  
 
                                                 
1
 Rasband, W.S., ImageJ, National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 
1997-2004 
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3.3.1 Influence on peroxisome abundance 
 
First, we analyzed the peroxisomal abundance, comparing the expression of all Pex11 
proteins to cells transfected with mCherry-SKL only. Two major questions were raised, 
namely i) whether the absolute number of peroxisomes changes and ii) whether the relative 
fraction of each category differs from cells transfected only with a peroxisomal marker 
protein. 
Figure 13-Figure 15 summarize the data collected for all Pex11 proteins from yeast, plant and 
man. Each table (Figure 13C-Figure 15C) shows the numbers themselves, highlighting the 
most important category. The absolute numbers are represented as bars in Figure 13A-Figure 
15A, whereas the relative abundance based on the total number of peroxisomes per cell are 
shown in Figure 13B-Figure 15B. 
 
Figure 13: analysis of the abundance of peroxisomes in cells overexpressing GFP-HsPex11α, β 
and γ; (A) total abundance of peroxisomes per widest focal plane/ cell, (B) relative distribution 
(sum of all peroxisomes=100%), (C) the exact numbers and standard deviations; n=50 cells;  
 
The blue bars in Figure 13-Figure 15 show the absolute and relative distribution of 
peroxisomes in wild type cells, i.e. cells transfected with a peroxisomal marker only. These 
cells contained approximately 90% peroxisomes in categories I and II, ~200 peroxisomes in 
total in the widest focal plane. The categories III and IV are hardly present.  
Overexpression of GFP-HsPex11α induced a shift towards smaller peroxisomes, as visible in 
Figure 13A/B. While the number of peroxisomes in category I increased, it decreased in 
category II as compared to wild type cells. The total abundance did not change. In contrast, 
GFP-HsPex11β expression led to an increase of both categories, but hardly altered the relative 
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distribution of the peroxisomes compared to cells expressing GFP-HsPex11α. More than 400 
peroxisomes were counted in one cell’s widest focal plane. When GFP-HsPex11γ was 
expressed the number of peroxisomes in category I and II was considerably reduced  but cells 
showed only minor changes in the other categories. However, due to the reduced total number 
of peroxisomes (approximately 100/ widest focal plane/ cell) the relative distribution reveals a 
severe increase in bigger peroxisomes, which here contribute to a fifth of the total peroxisome 
number. Notably, only cells containing big or clustered peroxisomes were counted since this 
phenotype was present in more than 80% of the transfected cells. 
 
 
Figure 14: analysis of the abundance of peroxisomes in cells overexpressing GFP-ScPex11 and 
25; (A) total abundance of peroxisomes per widest focal plane/ cell, (B) relative distribution (sum 
of all peroxisomes=100%), (C) the exact numbers and standard deviations; n=50 cells;  
 
Figure 14 shows the summary of the statistical evaluation of the yeast Pex11 proteins. 
Expression of GFP-ScPex11 led to more peroxisomes in such way, that a strong increase of 
category I was detected, while the other categories remained unchanged. Analysis of the 
relative distribution underlines this fact even better. Expression of GFP-ScPex25 led to nearly 
the same distribution as in cells expressing GFP-HsPex11γ. Though a slight shift toward 
smaller peroxisomes was observed in comparison to cells expressing GFP-HsPex11γ.  
The analysis of all plant Pex11 proteins is summarized in Figure 15. Expression of GFP-
AtPex11-1 caused a decrease in category II and an increase in category I. This, together with 
slightly more peroxisomes in category IV might result in the presumption that more big 
peroxisomes are present.  
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A strong shift towards big peroxisomes together with a decrease in all other categories was 
induced by expressing GFP-AtPex11-2. For GFP-AtPex11-3 expression the distribution of 
peroxisomes was comparable to that of wild type cells, though a slight increase in category I 
can be noted. Interestingly, expression of GFP-AtPex11-4 only led to marginally more 
peroxisomes in category IV and approximately the same amount in category II and III. This 
however, was enough to present some tubule-like structures as visible in Figure 11D (arrow). 
Clearly, expression of GFP-AtPex11-5 gave rise to a strong shift towards small and more 
peroxisomes. These findings will be further analyzed in section 3.3.3. 
 
 
 
Figure 15: analysis of the abundance of peroxisomes in cells overexpressing GFP-AtPex11-1 to 
-5; (A) total abundance of peroxisomes per widest focal plane/ cell, (B) relative distribution 
(sum of all peroxisomes=100%), (C) the exact numbers and standard deviations; n=50 cells;  
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3.3.2 Influence on peroxisome size 
 
We further analyzed the area covered by the peroxisomes of each category. Here, the same 
categories as described in section 3.3 (Table 2) were used.  
 
Figure 16: analysis of the covered area [µm2] of peroxisomes in cells overexpressing GFP-
HsPex11α, β and γ; (A) total area of peroxisomes per widest focal plane/ cell, (B) relative 
distribution (sum of area of all peroxisomes=100%), (C) the exact numbers and standard 
deviations; n=50 cells;  
 
Again, all peroxisomes in the widest focal plane were considered and the area of all 
peroxisomes of each category was summed up. This enabled us to detect any minor changes 
concerning the size of peroxisomes within each category.  
Figure 16 shows the statistics for the overexpressed human Pex11 proteins in HEK293T cells. 
In our experiments with GFP-HsPex11α, peroxisomes of category I and II covered the 
majority of all. This is in agreement with the counted abundance of the peroxisomes. 
Astonishingly, in the case of GFP-HsPex11β we observed approximately the same relative 
distribution as with GFP-HsPex11α, although a strong increase in the number of peroxisomes 
in category I was indicated before. Noteworthy, the covered area when GFP-HsPex11γ was 
expressed doubled as compared to wild type cells.  
Similarly to GFP-HsPex11α and β, the majority of peroxisomal area is covered by 
peroxisomes of category I for GFP-ScPex11 (Figure 17). Cells expressing GFP-ScPex25 
presented an even more pronounced shift to category IV as compared to cells expressing 
GFP-HsPex11γ.  
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Figure 17: analysis of the covered area [µm2] of peroxisomes in cells overexpressing GFP-
ScPex11 and 25; (A) total area of peroxisomes per widest focal plane/ cell, (B) relative 
distribution (sum of area of all peroxisomes=100%), (C) the exact numbers and standard 
deviations; n=50 cells;  
 
The expression of the plant Pex11 fusion proteins presented quite adverse results with regard 
to the covered peroxisomal area. The measurements are summarized in Figure 18. However, 
the total area covered by all peroxisomes of all categories did not change significantly 
throughout the cells expressing either of the used proteins (about 33µm2). 
 
 
Figure 18: analysis of the covered area [µm2] of peroxisomes in cells overexpressing GFP-
AtPex11-1 to -5; (A) total area of peroxisomes per widest focal plane/ cell, (B) relative 
distribution (sum of area of all peroxisomes=100%), (C) the exact numbers and standard 
deviations; n=50 cells;  
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3.3.3 A correlation appears between peroxisomal size and number  
 
Special interest has to be drawn at the correlation between the abundance and the size of 
peroxisomes. Since we used categories with a certain range, the covered area of peroxisomes 
might still vary within one category. For instance, there could exist fewer peroxisomes of 
category IV in a cell A that are bigger, and therefore cover a larger area than more 
peroxisomes of category IV in a cell B. In contrast, more peroxisomes in category I could also 
cover a smaller area than fewer but slightly bigger ones. The exact criteria defining the four 
categories can be found in Table 2. 
A significant index is easily accessible by dividing the mean size by the mean 
abundance of the peroxisomes in each category. The result is the area per peroxisome, giving 
a realistic view of size-changes within categories.  
The red-coloured numbers in Table 3 for the expression of HsPex11α and β explain the 
differences observed when comparing the abundance and the size of peroxisomes. The 
number of peroxisomes was higher for HsPex11β while the covered area stayed the same. 
This can only be explained by a different mean size of peroxisomes of category II which was 
doubled for HsPex11α. The most frapping differences occur in category IV, clearly due to its 
broad definition.  
 
 
 wt HsPex11A HsPex11B HsPex11C ScPex11 ScPex25 
cat I 0,08 0,09 0,05 0,06 0,09 0,05 
cat II 0,14 0,23 0,11 0,26 0,13 0,22 
cat III 0,39 0,65 0,39 0,44 0,52 0,55 
cat IV 1,45 2,04 0,89 1,68 1,39 2,02 
 
       
 
  
AtPex11-1 AtPex11-2 AtPex11-3 AtPex11-4 AtPex11-5 
 
cat I 0,10 0,09 0,09 0,09 0,08 
 
cat II 0,23 0,30 0,32 0,34 0,29 
 
cat III 0,68 0,43 0,59 0,56 0,52 
 
cat IV 1,44 2,30 1,05 1,17 1,32 
 
Table 3: average area of a typical peroxisome of each category for each used Pex11 protein; unit: [µm2] 
 
Overall, our results underline statistically the colocalization experiments and expand our 
knowledge by quantifying the relative differences in number and size of peroxisomes between 
the overexpression of the different Pex11 fusion proteins in human cells. 
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3.4 Effects of overexpressed Pex11 proteins over time 
 
The analysis of the tagged Pex11 proteins was always performed about 22-24 hours after 
transfection. Since peroxisomes are versatile organelles, observing the dynamics of their 
proliferation, growth and adaptation may be better suited to study the different effects allied 
with overexpression of Pex11 proteins. The best technique is by far live cell imaging, 
however, huge datasets are created when using this strategy. Therefore, it is absolutely 
necessary to narrow the timeframe to some distinct interesting points. Then, live observation 
is ultimately applicable with acceptable amounts of data.  
In order to achieve this, we decided to investigate the GFP-tagged Pex11 fusion proteins 
under the same conditions as before (see section 3.1) at different time points, namely 22h, 30h 
and 46h after transfection. 
 
3.4.1 Effects of human Pex11 proteins overexpression change over 
time 
 
Neither peroxisomal abundance nor size nor shape changed in cells cotransfected with 
plasmids expressing the peroxisomal matrix marker proteins, GFP-Scp2 and mCherry-SKL 
over the observed time frame (Figure 19D). The pattern of overexpressed GFP-HsPex11α did 
not change much over the observed timepoints; however, some increase in the peroxisomal 
abundance could be noticed (Figure 19A). The size of peroxisomes did not change in these 
cells. In contrast, when GFP-HsPex11β was overexpressed, the peroxisomal number, size and 
shape varied dramatically. The strong induction of peroxisome proliferation 22h after 
transfection shifted towards the formation of clusters observed 24h later.  
This was obviously achieved via an intermediate step (see Figure 20, crop of Figure 19). 
Here, the peroxisomal number decreased significantly as compared to 22h after transfection. 
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Figure 19: time-dependent expression of human GFP-Pex11 protein fusion constructs; (A) GFP-
HsPex11α showed no significant change over time, although some increase in peroxisome 
number was observable, (B) GFP-HsPex11β induces strong cluster formation after 46h, for 
zoomed region of interest see Figure 20; (C) GFP-HsPex11γ stimulates peroxisomal clusters to 
grow and/or fuse to enlarged groups of peroxisomes, images are projected stacks, red channel 
(A-D): mCherry-SKL, bar: 10µm 
 
 
 
 
 
 
 
 
 
Figure 20: outlined area of Figure 19, cell overexpressing GFP-
HsPex11β 30h after transfection; The green spots colocalize 
with the distinct red punctae (mCherry-SKL) and moreover, 
form a short tail which partly connects two red structures; 
sometimes, green fluorescence is observed as junction of more 
than two peroxisomes (arrow); bar: 10µm 
3. RESULTS  
 35 
Moreover, the individual peroxisomes (seen in red) seemed to be interconnected by a green 
structure, building up junctions for two or even more peroxisomes (see arrow in Figure 20 and 
Figure 21). A closer look at higher magnification on those structures revealed that in the 
majority of the cells some “ring-like” structures were visible only in the green channel 
(arrowheads in Figure 21), while red peroxisomal matrix marker, mCherry-SKL, stayed 
punctuate. Additionally, a green ring around a red dot could be observed (asterisks and crop 
in Figure 21) demonstrating that GFP-HsPex11β principally localized at the membrane. 
Whether the green rings observed represent an early step in peroxisome formation remains to 
be demonstrated. 
 
 
Figure 21: (A) and (B) highly magnified regions of interest of cells overexpressing GFP-HsPex11β 
30h after transfection; red: mCherry-SKL; arrows mark junctions between multiple peroxisomes, 
arrowheads highlight ring structures and asterisks notate green encircled peroxisomes, bar: 5µm, (c) 
and (d) one region has been cropped and transformed in grey, where (c) represent the red channel 
and (d) the green one; bar: 1µm; all images are projected stacks 
 
However, the above mentioned solely green ring- structures seemed to be an effect due to 
high overexpression, since it could be shown that all human Pex11 proteins as well as 
ScPex11 and ScPex 25 were able to form such structures upon high overexpression (data not 
shown). Nevertheless, only overexpressed GFP-HsPex11β led to interconnected peroxisomes 
30h after transfection. This was not observable with any other protein. Remarkably, these 
structures all disappeared 46h after transfection, where some peroxisomal clusters could be 
observed together with some small peroxisomes. Here, the peroxisomal marker mCherry-SKL 
was also visible in the cytosol, though to a less extent so that the peroxisomes stayed brighter 
marked (data not shown).  
Overexpressed GFP-HsPex11γ showed the clustering after 22h to some extent as observed 
before (Figure 6C). Again, the majority of the cells showed this phenotype, the rest of the 
cells contained normal-sized peroxisomes (shown in Figure 19C as compared to clusters 
shown before in Figure 6C). This changed over the time in such way, that all cells presented 
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enlarged or clustered peroxisomes. This shift was clearly observable as the percentage and the 
size of clusters per cell was growing continuously at each time point.  
 
3.4.2 Overexpression effects of yeast proteins of the Pex11 family 
change over time 
 
The overexpressed GFP-ScPex11 protein induced the formation of many peroxisomes already 
22h after transfection. This did not change over time as visible in Figure 22A. Here, the 
morphology, size and abundance were not affected as compared to time point 22h.  
 
 
Figure 22: time-dependent expression of the yeast GFP-ScPex11 and GFP-ScPex25 fusion proteins; (A) 
GFP-Pex11 shows no significant change over time whereas (B) the clustering observed after 
overexpressing GFP-Pex25 increases, (C) GFP-Scp2; red channel (A-C): mCherry-SKL, images are 
projected z- stacks, bars: 10µm 
 
The overexpressed GFP-ScPex25 which induced some clustering even 22h after transfection 
induced this clustering together with tubule-formation extensively until 46h after transfection 
(see Figure 22B). The smaller window in Figure 22B/46h shows an enlarged cell area which 
presents tubule-like structures. 
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3.5 SNAP-tag technology – a tool to study protein dynamics  
 
The concept of tagging has allowed to establish new ways to analyze protein functions. A tag 
makes it possible to follow a protein in vivo via live-cell imaging, to detect it in a Western 
blot or to isolate and purify it via a column. Whatever task a tag is assigned with, several 
requirements have to be fulfilled. A fluorescent tag such as GFP should be as small as 
possible, not interfere with the protein’s function, be photostable and have a short maturation 
time. Moreover, the quantum yield, the extinction coefficient and pH (in)sensitivity play a 
role, too.  
Several new approaches have arisen since the cloning of the gene coding for avGFP 
including fluorescent peptide ligands, photoactivatable and photoswitchable fluorescent dyes 
(Chapman et al., 2005, Griffin et al., 1998; Shaner et al., 2007).  
In our experiments, we searched for a tag that would enable us to perform both, 
imaging and biochemical experiments. Finally, we chose the SNAP® tag due to its multiple 
advantages. SNAP® stands for a protein, namely the human O6-alkylguanine-DNA-
alkyltransferase (hAGT). It transfers irreversibly the alkyl group from its substrate O6-
alkylguanine-DNA, to its reactive cysteine residue (Figure 23). Combined biochemical and 
structural-biological methods led to a proposed reaction mechanism (Figure 23, Daniels et al., 
2004). 
 
      Figure 23: proposed reaction mechanism of hAGT (Daniels et al., 2004). 
 
The essential role of hAGT in DNA damage repair has been studied extensively making this 
protein a functionally clarified one (Daniels and Tainer, 2000, Wibley et al., 2000, Xu-
Welliver et al., 1999, Xu-Welliver et al., 2000, Xu-Welliver and Pegg, 2000). Additionally, 
hAGT represents an interesting target for pharmaceutical screens. Since alkylated DNA can 
induce apoptosis, chemotherapeutic strategies based on DNA-alkylating agents (e.g. 
temozolomide) have a reduced efficiency due to the endogenous hAGT reversing the effects 
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of such drugs. Therefore, medics inhibiting hAGT increase dramatically the effects of DNA-
alkylating drugs (Ragg et al., 2000, Cai et al., 2000, Damoiseaux et al., 2001; Griffin et al., 
2000, Meikrantz et al., 1998). 
All these studies on hAGT revealed that the specificity for its substrate only requires 
the structure O6-benzylguanine (BG). Therefore, any fluorescent dye coupled on BG would 
lead to a specific labelling of hAGT. The endogenous hAGT has been mutated several times 
to eliminate the disadvantages it may have when serving as a tag. Its intrinsic affinity for 
DNA was efficiently reduced, its activity for BG substrates was increased and its size was 
minimized by removing non-essential amino acid residues (Juillerat et al., 2003, Gronemeyer 
et al., 2006, Heinis et al., 2006). This enables to work in cells that are not deficient for hAGT. 
One drawback of this approach still remains: Since the enzyme hAGT is not longer valuable 
after the transfer reaction, it is ubiquitinylated and degraded by the cell. However, the 
measured decrease of fluorescence in labelled living cells is about 50% after 7 hours (Keppler 
et al., 2004b, Srivenugopal et al., 1996). 
The idea of using hAGT as a tag was first introduced in 2003 (Keppler et al., 2003) 
and has continuously been refined by developing new substrates over the years (Keppler et 
al., 2006; Keppler et al., 2004a; Keppler et al., 2004b).  
An enormously valuable feature of the SNAP® tag (provided by Covalys) is the versatility to 
any BG substrate offered, be it in living cells, fixed cells or a BG immobilized on a surface, 
which makes protein purifications easily possible (Kindermann et al., 2003).  
We expanded this technology by appending the SNAP® tag with a tobacco etch virus (TEV) 
protease cleavage site in order to pull down purified proteins from a matrix.  
Eventually, our SNAP®-TEV tag will represent a useful tag for any kind of imaging and 
protein purification procedures.  
 
3.5.1 Peroxisomal dynamics in live cell imaging  
 
Several fluorescent dyes are available for imaging the SNAP® protein. We chose a red and a 
green label (TMR-Star and BG505, respectively), since these suited well with our peroxisome 
marker proteins (Figure 24).  
To achieve our goals, we cloned N-terminally SNAP-TEV-tagged Pex11 fusion proteins, and 
evaluated then. We expressed SNAP-TEV-HsPex11α and γ in HEK293T cells, also 
expressing GFP-Scp2 and labelled the cells with the TMR-Star dye. 
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Figure 24: fluorescent labels for the SNAP® tag used; (A) BG-505, exc: 504nm, em: 532nm, (B) TMR-Star, 
exc:554nm, em:580nm 
 
As control for the SNAP® technology, we transfected a plasmid encoding SNAP®-tagged 
cytochrome oxidase 8A (Cox8A), a mitochondrial protein. Cells were imaged alive with the 
 
 
Figure 25: live cell imaging of HEK293T cells expressing labelled 
SNAP fusion proteins 24 hours after transfection, (A) SNAP-TEV-
HsPex11α, (B) SNAP-TEV-HsPex11γ, (C) Cox8a-SNAP, (A-C) 
coexpressed with GFP-Scp2, images are projected z-stacks of one 
time frame, bar: 10µm 
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Zeiss DuoScan (Figure 25, see methods section for details). The control cells in Figure 25C 
presented a normal morphology. The mitochondrial network was properly established. 
Peroxisomal abundance, size and shape were comparable to cells transfected with mCherry-
SKL or GFP-Scp2 only (Figure 6). Moreover, cells overexpressing SNAP-TEV-HsPex11α or 
γ showed identical peroxisome number and size as cells overexpressing the GFP tagged 
Pex11 proteins (Figure 6). Similar results were obtained with fixed cells labelled prior 
fixation. Evaluation of the BG-505 dye revealed that this dye was not that sensitive, bright 
and photostable than the red TMR-Star. Therefore, combining GFP-Scp2 with a red labelled 
SNAP® tag proved as best choice. 
 
3.5.2 Establishing stable cell lines 
 
For further study using the SNAP® tag, it is absolutely necessary to establish stably 
expressing cell lines for each Pex11 construct. We chose to establish stably transfected 
HEK293T cells expressing either mCherry-SKL, GFP-Scp2, SNAP-TEV-HsPex11α and 
SNAP-TEV-HsPex11γ. Briefly, HEK293T cells (passage 11) were transfected, one day after 
the appropriate selective agent was added. When most cells had died, each dish was split and 
diluted into a 96-well in such way, that one single cell was present in one well. These cells 
were grown to confluency, transferred to a 48-well. After repeated growth and splitting, cells 
were ready in passage 18.  
 
 
Figure 26: HEK293T cells stably expressing (A) GFP-Scp2 and (B) mCherry-SKL, images are projected 
z-stacks, bar: 10µm 
 
 
The clones expressing the peroxisomal marker proteins GFP-Scp2 and mCherry-SKL 
were successfully tested (see Figure 26), now called HEK293TGFP-Scp2 and HEK293TmCherry-
 SKL
, respectively. Every single cell presented wild-type like peroxisomes with very bright 
3. RESULTS  
 41 
fluorescence. Fortunately, every single clone exhibited a similar fluorescent pattern as 
compared to cells transiently transfected with the respective peroxisome marker. The 
emission was significantly brighter for HEK293TmCherry-SKL resulting in bigger peroxisomes as 
compared to HEK293TGFP-Scp2, since the images were aquired using the same settings. 
 
3.6 Study on domains and possible posttranslational 
modifications of Pex11 proteins 
 
Elucidating the molecular role of the Pex11 proteins involves multiple approaches. Among 
those already employed, testing the importance of certain domains on the protein function 
could provide a first hint where to focus on while pinpointing the specific function in 
peroxisomal proliferation.  
After scrutinizing the three human Pex11 proteins bioinformatically, we identified two 
putative phosphorylation sites for HsPex11α as well as the putative transmembrane domains 
for HsPex11α and β. 
 
3.6.1 Mutations of putative phosphorylation sites affects the 
phenotype 
 
 
We identified a double phosphorylation site at serine 159/ serine 161 of HsPex11α via a 
bioinformatical search (PhosphoELM, http://phospho.elm.eu.org/, Diella et al., 2004; Diella et 
al., 2008). The mutation of these serines to alanines (SA) blocks possible phosphorylation 
and mimicks the unphosphorylated state whereas the mutation to aspartates resembles the 
phosphorylated state due to the high negative charges present. HsPex11α could be regulated 
via phosphorylation events, maybe another functional control together with a possible redox-
sensitive dimerization (Marshall et al., 1996). We introduced both double mutations in 
HsPex11α, now called HsPex11αSA and HsPex11αSD. We observed the expression of both 
proteins N- terminally tagged with GFP in HEK293T cells (Figure 27). 
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Figure 27: HEK293T cells expressing (A) GFP-HsPex11αSA 
and (B) GFP-HsPex11αSD; (A) showing interconnected 
peroxisomal tubules, whereas in (B) the peroxisomal structures 
are more clustered and enlarged. images are projected stacks, 
(A-B) cotransfection with mCherry-SKL, bar: 10µm 
 
The expression of GFP-HsPex11αSA caused peroxisomal tubule-formation, where the 
formed tubules are strongly interconnected (Figure 27A). In contrast, the overexpressed SD 
mutation of HsPex11α led to a distinct phenotype, where the peroxisomes appeared more 
clustered than elongated. Of course, the endogenous HsPex11α was still present among the 
other members of the Pex11 protein family, whose interplay remains obscure. Despite these 
facts, the phenotypes observed make it necessary to investigate the singly mutated HsPex11α.   
 
3.6.2 The transmembrane domain is important for localization and 
function  
 
The careful bioinformatical scrutiny of the various Pex11 proteins revealed a transmembrane 
domain (TMD) for HsPex11α and β near the C-terminus (Kyte-Doolittle plot in Figure 28, 
Kyte and Doolittle, 1982). As easily visible in Figure 28, the hydropathy plots of HsPex11α 
and β are quite similar, whereas HsPex11γ exhibits different hydrophilic properties. Deletion 
of 60 base pairs of the cDNA coding for HsPex11α (aa 220-239) and 78 base pairs of the 
respective cDNA for HsPex11β (aa 230-255) would delete those TMDs, thus retaining the 
earlier discussed KxKxx motif of HsPex11α and the RxKx motif of HsPex11β. The real 
nature of the mPTS is yet unclear, it is only verified that one TMD is required for insertion 
into the peroxisomal membrane.  
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Figure 28: Kyte-Doolittle plots for the full-length human Pex11 proteins, (A) HsPex11α, (B) 
HsPex11β and (C) HsPex11γ, crossing the red line indicates a highly possible putative 
transmembrane domain, window size for A-C: 19 amino acids 
 
We deleted the above indicated amino acids of HsPex11α and HsPex11β, now called 
HsPex11α∆20 and HsPex11β∆26, respectively, by means of PCR and expressed these proteins 
as N-terminal GFP-fusions in HEK293T cells stably expressing mCherry-SKL 
(HEK293TmCherry-SKL).  
 
 
Figure 29: C-terminal deletion mutants of HsPex11α and β missing the 
putative TMD in HEK293T cells stably expressing mCherry-SKL; (A) 
GFP-HsPex11α∆20 and (B) GFP-HsPex11β∆26; (A-B) images are 
projected stacks, bar: 10µm 
 
GFP-HsPex11α∆20 did not colocalize to peroxisomes, it was found in the cytosol. 
Interestingly, the cells expressing this truncated version of HsPex11α contained fewer and 
larger peroxisomes as compared to the surrounding cells only expressing the marker protein. 
Moreover, the expression level of GFP-HsPex11α∆20 seemed to negatively correlate with the 
peroxisome number (Figure 29A). This fact was not observable in cotransfection experiments, 
since the loss of red fluorescence from the marker proteins could be interpreted as reduced 
labeling of peroxisomes. This bias was eliminated in cells stably expressing the mCherry-
SKL. Colocalization experiments in HEK293TmCherry-SKL cells with untruncated Pex11 
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proteins of either used kingdom showed the same results as presented before (see section 3.1). 
These findings could correlate localization and functionality of HsPex11α. 
 We further tested whether other organelles were affected as well by overexpressed 
GFP-HsPex11α∆20 by analyzing the nucleus, the golgi, the mitochondria and actin as 
important part of the cytoskeleton. We could not find any differences between cells 
overexpressing GFP-HsPex11α∆20 or the peroxisomal matrix marker GFP-Scp2 only. Further 
tests will include the ER, tubulin and a marker for the peroxisomal membrane, PMP70. The 
latter will show, whether only the import of PTS1-dependent proteins is inhibited or whether 
peroxisomal number is reduced at all.  
The overexpressed GFP-HsPex11β∆26 behaved similarly in HEK293TmCherry-SKL cells, as it 
was found in the cytosol and the nucleus, sometimes forming aggregates. However, cells 
overexpressing GFP-HsPex11β∆26 presented a normal peroxisomal abundance and 
morphology comparable to cells only expressing mCherry-SKL (Figure 29B).  
 
3.6.3 ScPex11 possibly forms redox-sensitive homodimers in 
human cells 
 
It has been reported before that a possible redox-sensitive homo-dimerization of ScPex11 
might regulate its function in the proliferating machinery in yeast cells (Marshall et al., 1996). 
CbPex11 contains only one cysteine, which is not fully conserved in ScPex11 that contains 
three cysteine residues. However, comparing the surrounding amino acids of each cysteine of 
ScPex11 to the one in CbPex11 reveals one similar cysteine, cys3. Marshall et al. introduced a 
cysteine to alanine (CA) mutation in ScPex11 and expressed it under the Pex11-promoter in 
a pex11 mutant yeast strain. The morphology and abundance of the yeast peroxisomes were 
affected significantly, since more and clustered peroxisomes were present (Marshall et al., 
1996).  
We already demonstrated that the yeast ScPex11 protein sorts to peroxisomes in human cells. 
Moreover, upon overexpression of this protein, the cells contained about 55% more 
peroxisomes than cells expressing only mCherry-SKL.  
We introduced the same mutation in ScPex11 by changing the codon three from TGT(cys)  to 
GCT(ala). Overexpressing an N-terminally GFP-tagged version of this protein in 
HEK293TmCherry-SKL cells induced clustering and elongation of peroxisomes (Figure 30). In 
some cases many small peroxisomes were present as well in the cell, which could represent 
the amount of overexpression in each cell. 
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Figure 30: overexpressed GFP-ScPex11CA in HEK293TmCherry-SKL cells; (A) clustering and 
elongation of peroxisomes are present in cells expressing this protein, (B) some cells contain 
additionally small peroxisomes, image is a projected stack, bar: 10µm 
 
The results of our study in human cells are similar to those observed from Marshal et al. in 
Candida boidinii, which could reflect an universal mode of regulation for the Pex11 proteins 
from yeast and human cells. 
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4 Discussion 
 
Generally, the proliferation of all organelles is ultimately required for cell division and growth 
of cells, organisms and therefore life. Peroxisomes, though little in size, perform multiple 
important tasks. As they participate in the lipid metabolism and detoxify hydrogen peroxide 
via their enzymatic machinery, they are essential for most eukaryotic cells. Indeed, human 
cells containing aberrant peroxisomes or missing these organelles are hardly viable. Thus, 
most peroxisomal biogenesis disorders are lethal for humans.  
Peroxisomes adapt to given environmental conditions or cellular requirements rapidly, 
making these organelles versatile. One important path of peroxisome proliferation is given by 
the fission of preexisting peroxisomes (Figure 31). Several proteins are involved in this multi-
step process. 
 
Figure 31: schematic drawing of the peroxisomal proliferation by fission 
 
Among those proteins the Pex11 protein family plays an important role. In humans, three 
genes coding for HsPex11α, β and γ have been identified (Abe and Fujiki, 1998, Abe et al., 
1998, Tanaka et al., 2003). Although, many years have passed since then, major questions 
have not been resolved yet. Why are there more than one Pex11 protein in a given organism? 
What is the difference in their function, do they work together or to what extent are they 
distinct? In plants, the five AtPex11 proteins are known to be expressed in different tissues at 
different levels and act at strongly regulated time points (Orth et al., 2007, Lingard et al., 
2008). However, even single cell organisms such as baker’s yeast contain three proteins of the 
Pex11 family. All together, the sequences of these different Pex11 proteins are quite 
conserved.  
In humans, HsPex11α is – in contrast to the other two proteins – inducible. Pex11β 
seems to play a major role within the constitutively working division machinery. An 
interaction between HsPex11β and Fis1 could be proven biochemically (Li and Gould, 2003, 
Kobayashi et al., 2007). The function of HsPex11γ has not been elucidated, yet. However, it is 
the only member of the human Pex11 protein family, that induces clustering and not division 
of peroxisomes upon overexpression (this study, Li et al., 2002a). It certainly has to be 
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clarified whether an untagged version of this protein leads to the same effects on peroxisomes 
as its tagged counterparts.  
Here, we could show the colocalization of overexpressed GFP-tagged Pex11 proteins from 
three different kingdoms with a peroxisomal matrix marker protein in human HEK293T cells. 
Overexpression of GFP-HsPex11α or β induced peroxisomal proliferation as more 
peroxisomes were visible as compared to cells tranfected only with the peroxisomal marker 
protein (Figure 6). In contrast, overexpressed GFP-HsPex11γ led to larger and clustered 
peroxisomes. It has been reported that in yeast, peroxisomes stick together after fission. The 
separation may require the function of the proteins ScPex28-29 (Figure 3, Vizeacoumar et al., 
2003). In agreement with these published data, our observations could be a hint for 
proliferation as well. 
However, many other explanations are possible; it could be that HsPex11γ is such a 
powerful proliferating factor, that the fission machinery is overwhelmed. It might also be that 
HsPex11γ is actively inhibiting the fission machinery or at least the separation process. It had 
been shown, that the knockdown of some proteins of the peroxisomal/mitochondrial fission 
machinery in human cell results in elongation – “sausage-like” – of peroxisomes. Our 3D 
reconstitutions enable to judge whether more than one peroxisome are involved in one cluster 
induced by overepxressed GFP-HsPex11γ. It seems, that there were more peroxisomes 
present in most clusters as observable via the 3D contours of the clusters (Figure 10). Still, 
they were connected to each other and not well separated. However, though this clustering 
was present in the majority of the cells, some cells contained an equal amount of peroxisomes 
of about the same size as compared to cells transfected only with mCherry-SKL. 
Interestingly, overexpressed yeast and plant GFP-Pex11 fusion proteins sorted to human 
peroxisomes in HEK293T cells (Figure 7/ Figure 8). Here we could show that the presented 
phenotypes resemble at least partly the overexpression of human GFP-Pex11 fusion proteins. 
For instance, overexpressed GFP-ScPex25 induced clusters comparable to HsPex11γ, whereas 
GFP-ScPex11 led to a strong increase of the peroxisomal abundance as did HsPex11α. 
Among the plant proteins, overexpressed GFP-AtPex11-3, -4 and -5 induced peroxisomal 
proliferation. Overexpressed GFP-AtPex11-1 mildly and GFP-AtPex11-2 strongly induced 
cluster formation.  
Obviously, there exist common elements in the overexpression phenotypes of the 
GFP-Pex11 fusion proteins of the three kingdoms. Still, the implications of cluster formation 
on molecular function need to be investigated further. If the fission machinery cannot cope 
with the activity of certain Pex11 proteins, why are rather clusters than elongated peroxisomes 
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observable? If some Pex11 proteins act as inhibitors of peroxisomal proliferation, do they 
block the fission process itself or the concerted elongation of peroxisomes driven by other 
Pex11 proteins?  
Most of the Pex11 proteins from each studied kingdom are membrane-bound or -associated 
proteins. Some might exhibit a full TMD. The import of PMPs is not fully understood, yet. As 
summarized by Brown and Baker in 2003, the theory is now accepted that PMPs exhibiting a 
single TMD contain a patch of positively charged amino acids adjacent to this TMD though 
no consensus sequence could be identified. In PMPs that contain more than one membrane 
spanning domain, the cooperation of multiple regions within the protein and a loop on either 
side of one TMD is required for correct localization (Brown and Baker, 2003). The common 
element is at least one TMD being essential for insertion. Moreover, a complete mechanism 
for the insertion of PMP into the peroxisomal membrane has not been found, either. Two 
putative pathways have been postulated; i) the PMP is translated on free polysomes, interacts 
with Pex19 and is then inserted with the help of other proteins such as Pex3 or ii) PMPs are 
sorted via the ER, bud at defined regions, maybe marked by the presence of Pex3, and 
eventually fuse with existing peroxisomes demanding PMPs (for review see Tabak et al., 
2008). 
We may conclude from our colocalization studies that whichever mechanism might be 
true it is conserved throughout the three studied kingdoms. All investigated Pex11 proteins 
sorted to peroxisomes, each of them resulting in a slightly different phenotype suggesting 
their possible functionality in human cells. Either the mPTS is widely recognized without any 
species- or even kingdom-specificity or a more subtle signal is responsible for being 
recognized by the import machinery and finally, being inserted in the peroxisomal membrane.  
Either way, the membrane topology and orientation of each protein has to be investigated. 
Some experiments have already been performed, e.g. ScPex11 is proposed to face the 
peroxisomal matrix with both, its N- and C- terminus in yeast (Marshall et al., 1996). We seek 
to investigate this topic if the orientation changes when expressed in human cells by means of 
biochemical redox-sensitive crosslinking (e.g. PEG-maleimide, see below). This experiment 
would enable to not only determine the topology of the studied protein in the membrane but 
as well to analyze its redox-sensitive residues outside the membrane.  
4.1 Peroxisome membrane dynamics  
 
We were able to quantify the abundance and the size of peroxisomes in HEK293T cells. We 
compared the overexpression phenotypes of all studied GFP-Pex11 fusion proteins to cells 
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transfected with mCherry-SKL only. Basically, we could confirm the data already evaluated 
visually. Due to the complex counting strategy, we decided to use only one focal plane 
(width: 0.5µm) of a cell, where the most peroxisomes could be detected. Of course, more 
peroxisomes than counted via this method are present in a cell. However, since we compared 
numbers and sought to outline trends rather than presenting absolute numbers this strategy 
was useful. Especially, the area of a peroxisome was actually obtained by measuring the area 
of the fluorescent dot. Still, this procedure was applicable because we only compared areas 
within each category. We divided the peroxisomes into four categories (Table 2) with 
growing size in order to easily observe shifts in the distribution due to overexpressed GFP-
Pex11 proteins. We showed that big and clustered peroxisomes occurred predominately upon 
overexpression of GFP-HsPex11γ or GFP-ScPex25, a fact that was even more pronounced 
when looking at the area occupied by the enlarged peroxisomes (Figure 13/ Figure 14/ Figure 
16/ Figure 17). This clustering was also induced by overexpressed GFP-AtPex11-1 and -2. 
Especially GFP-AtPex11-2 expression led to the formation of very few large peroxisomes. 
Here, no increase in number could be detected compared to cells transfected with mCherry-
SKL only. However, these few peroxisomes covered more than twice the area than did the 
larger peroxisomes in cells transfected with mCherry-SKL only. This discrepancy may be 
attributed to internal variations within the defined categories. We defined four categories each 
with a certain range. Therefore, the size can vary within each category, particularly in 
category IV due to its wide range (Table 2). In order to overcome this problem to some 
extent, we calculated the mean size of a typical peroxisome of each category (Table 3).  
 
 wt HsPex11A HsPex11B HsPex11C ScPex11 ScPex25 
cat I 0,08 118% 68% 75% 109% 66% 
cat II 0,14 169% 78% 186% 98% 157% 
cat III 0,39 164% 99% 113% 133% 140% 
cat IV 1,45 141% 61% 116% 96% 139% 
 
            
 
  
AtPex11-1 AtPex11-2 AtPex11-3 AtPex11-4 AtPex11-5 
 cat I 120% 112% 114% 108% 99% 
 cat II 168% 219% 233% 245% 212% 
 cat III 171% 110% 149% 141% 132% 
 cat IV 99% 159% 73% 81% 91% 
 
Table 4: average area of a peroxisome of each category as percentage compared to peroxisomes of cells 
transfected with mCherry-SKL only; unit (wt): [µm2] 
 
The values expressed as percentage compared to that of cells only transfected with mCherry-
SKL allow to better perceive the differences (Table 4). Notably, the standard deviations 
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behind these values have to be considered, too. Yet, since the relative average size of 
peroxisomes derives as means of means their standard deviations are not listed in Table 4. 
Most importantly, the overall average peroxisomal area covered in the widest focal plane was 
in most case approximately the same in each cell. Despite all the discussed drawbacks of the 
size determination via fluorescence measurements, our observations point directly at the issue 
of membrane dynamics. Where do peroxisomes get their membranes from? Are vesicles 
delivering lipids engulfed by a peroxisome just before it divides? Or does a mature “ready-
for-fission”- peroxisome first fuse with an immature one? Here, live cell imaging certainly 
will provide new insights, since it should be possible to observe the events of peroxisome 
fission especially when forced by an overexpressed protein acting as a proliferating agent.  
 
4.2 HsPex11β – a construction site for new peroxisomes 
 
We scrutinized the behaviour of peroxisomes over time, upon expression of each GFP-Pex11 
protein fusion. Especially, overexpressed GFP-HsPex11β induced various changes in 
peroxisome shape and size. First, many peroxisomes are formed which then form tubules and 
subsequently large fluorescent structures. We found complete colocalization of the GFP 
signal and the mCherry-SKL signal. However, the tubules observed showed massive green 
fluorescence within two or more red structures. This finding was reproducible. Similar 
structures were observable at more or less the same time points. This could be interpreted in 
several ways. It seems very unlikely that this behaviour just occurs as a result of 
overexpression. In that case, on the one hand the finding would not be as exactly reproducible 
and on the other hand similar plasmids coding for other Pex11 proteins would behave 
comparably, which was not the case (e.g. Figure 19A&C, Figure 22). Therefore, it is most 
likely that a correlation exists between the function of HsPex11β and the observed structural 
changes of the peroxisomes. Again, the question might arise whether cluster formation is a 
consequence of an overwhelmed fission machinery.  
 
Figure 32: schematic drawing of the possible participation of HsPex11β in the elongation step; 
(A) two peroxisomes connected by a tunnel formed at the site of HsPex11β, (B) HsPex11β 
induces tubule formation at one specific site on a peroxisome, Px: peroxisome 
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Though more detailed studies are necessary, much evidence points at this idea. In the 
schematic drawing shown in Figure 32A we propose that the structures observed represent 
connections between dividing peroxisomes. HsPex11β could form a tube-like structure 
around the channel formed by the budding peroxisome. The green fluorescence concentrates 
at one distinct point and of course, the channel would be very thin exhibiting a too weak 
signal for detection. Figure 32B shows a possible explanation for the observation of single 
peroxisomes exhibiting a green tail (visible in Figure 20). It could represent a state 
immediately prior or post fission. As stated before, it has been shown that HsPex11β recruits 
Fis1 to the peroxisomal membrane which itself interacts with Dlp1 (Kobayashi et al., 2007). 
Dynamin-like proteins have been reported as possible mechanochemical machines, 
facilitating the budding of vesicles (for review see Praefcke and McMahon, 2004). At least, it 
has been shown that Dlp1 and Fis1 are part of the mitochondrial and peroxisomal fission 
machinery (Koch et al., 2005). It would be reasonable to think that HsPex11β, the initial 
regulator of this process, provokes the budding of peroxisomes at one defined membrane 
region. However, some structures in Figure 21 consist of more than two peroxisomes. The 
overexpression of HsPex11β might disregulate the whole process and consequently force this 
budding effect at more than just one site. 
Importantly, we have to consider that dynamin related proteins are also involved in fusion 
processes, such as e.g. mitofusins in mitochondrial fusion. It could be that the intermediate 
step observed with HsPex11β represents a fusion of pre-existing peroxisomes. Further 
speculation might give rise to the question whether the peroxisomal clusters induced by 
overexpressed GFP-HsPex11γ are indices for dividing or fusing peroxisomes. 
However, the role of the other two Pex11 proteins has to be considered beyond that 
speculation. Nevertheless, HsPex11β, being the non-inducible form, could be responsible for 
fission via the constitutive pathway, whereas HsPex11α might only be present upon induction 
as reaction to e.g. oxidative stress. Interestingly, the highest levels of Pex11α were found in 
liver tissue (Li et al., 2002a).  
 
4.3 HsPex11α contains an essential transmembrane domain 
 
We could show that the deletion of 20aa (aa 220-239) of HsPex11α is necessary for 
localization to peroxisomes, since we observed a cytosolic GFP-signal upon overexpression 
of GFP-HsPex11α∆20 in HEK293T cells (Figure 29). Moreover, we observed a negative 
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correlation between GFP-HsPex11α∆20 expression levels and the abundance of peroxisomes. 
The peroxisomal number was strongly reduced in cells expressing this truncated version of 
HsPex11α, whereas other organelles were not affected. Since the endogenous proteins of the 
Pex11 family were still present, the truncation seemed to exert a dominant negative effect. 
Interestingly, truncated HsPex11β being similar to HsPex11α in the Kyte-Doolittle plot, 
behaved similarly when overexpressed in HEK293T cells as well. Its localization is cytosolic 
and nuclear. However and most importantly, peroxisomal abundance and morphology was not 
effected upon overexpression of GFP-HsPex11β∆26. It is noteworthy that the KxKxx motif of 
HsPex11α and the RxKx motif of HsPex11β were still present in the mutated versions of 
these proteins, allowing a possible function or regulation of these ER-related motifs to be 
exerted. 
Maybe the transmembrane domain does not only control the localization, but also the function 
of HsPex11α. After insertion into the membrane, HsPex11α could get phosphorylated, which 
might inhibit its redox-sensitive homodimerization and/ or enable other interactions. When 
not needed anymore, the phosphate could be removed and HsPex11α might be able to 
dimerize. This could cause a change in its conformation; the HsPex11α might no longer be 
stably inserted into the membrane, and upon removal could be degraded in the cytosol. 
Therefore, overexpression of HsPex11α∆20 leads to non-dividing peroxisomes, though these 
are actually needed. Of course, the exact localization needs to be determined. We will perform 
experiments using PEG/ maleimide in the presence and absence of DTT in order to answer 
these questions. Here, methyl-PEG-maleimide reacts with thiols making a pegylated protein 
heavier and thus visibly shifting its band on a SDS-PAGE gel. mPEG is not membrane 
permeable, therefore allowing to assess the reactive cysteine residues outside the membrane. 
By cautiously varying the reaction conditions, we will be able to determine redox-sensitive 
thiol groups of the Pex11 proteins since the mentioned reaction can be moderated by redox-
reactive SH reagents that are i) small, hydrophilic impermeant or ii) small membrane- 
permeant in order to block available cysteines prior to pegylation (Lu and Deutsch, 2001).  
It remains to be clarified, why the endogenously expressed proteins are not overruling the 
phenotype of aberrant peroxisomes. This mutation must have a dominant negative effect, 
possibly affecting the other proteins as well maybe through dimerization with α or β or other 
members of the peroxisome proliferation machinery. Here, HsPex11γ could take over the 
control and act as inhibitor of peroxisomal fission leading to this dramatic phenotype. Another 
possible role for HsPex11γ could be to regulate HsPex11α and β. Given, that HsPex11β was 
responsible for the constitutively promoted fission process and HsPex11α acted as additional 
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stimulator when needed, HsPex11γ could bind to those two proteins, maybe inhibiting their 
interactions with other proteins, necessary for fission.  
Especially the redox-sensitivity of the model proposed above is supported by the phenotype 
of the overexpressed GFP-ScPex11cod3 which led to enormous clustering and enlargement of 
peroxisomes (Figure 30).  
Whatever process is taking place in the cell to promote proliferation of peroxisomes, it is a 
highly regulated one. 
 
4.4 Conclusion and future aims  
 
Our analysis of ten proteins of the Pex11-family in human cells has already provided 
interesting hints on the conservation of the peroxisomal proliferation machinery between 
yeast, plant and human cells. In future experiments we will focus on the dynamics of 
peroxisomal biogenesis by implementing live cell imaging, biochemical experiments and 
other cell biological approaches.  
We established a technique for live cell imaging to observe peroxisome fission and the 
participation of each protein in vivo. Moreover, the SNAP-TEV-tag introduced provides the 
opportunity for protein purification as well. A remarkable feature of this tag lies in its ability 
to form a covalent bondage between its reactive cysteine and the substrate. We will use this 
for a multi-color assay in live cell imaging. We will label our protein of interest at time point 
zero with one fluorescent dye. After several hours of observation, the newly synthesized 
protein will be labeled with another dye. This step can be repeated several times. The only 
drawbacks are the degradation of the labeled SNAP protein and the limited amount of 
separable fluorescent dyes. However, we have a large time window of about seven to ten 
hours where a labeled SNAP tag is still stable. Alternatively, we can always observe the cells 
labelled with different dyes after fixation. Live observations will certainly enable us to get an 
even closer look on the function of the proteins of the Pex11 family.  
Furthermore, we plan to perform coimmunoprecipitation experiments in order to isolate 
interaction partners of each human Pex11 protein. Here, the already known binding partners 
could prove as good positive controls (e.g. Pex19 for HsPex11α and Fis1 for HsPex11β). A 
very interesting topic in the context of evolutionary conservation of the peroxisomal 
proliferation machinery will be the scrutiny for interaction partners of yeast and plant Pex11 
proteins in human cells. Finally, we seek to compare the found interaction partners of every 
Pex11 protein in each organism. Some interesting truncations will be investigated, too.  
4. DISCUSSION 
 55 
We will establish an additional approach by testing the effect of siRNA against the human 
Pex11 proteins. We designed and cloned two siRNAs per PEX11 cDNA into the plasmid 
pSilencer 2.1 U6 hygro, which enables us to use these vectors for small hereditary RNA 
(shRNA) experiments. Here, we will be able to investigate the effects in long-term studies and 
to verify whether the viability of cells with any knocked-down Pex11 protein is affected. In 
addition to the necessary tests including western and northern blotting, we designed a 
scrambled 19-mer siRNA in order to exclude plasmid-derived phenotypes. Since the used 
vector contains a hygromycin resistance, we can use this system together with our established 
HEK293TmCherry-SKL or HEK293TGFP-Scp2 cell line. 
A quite important role is attributed to the host system used. We decided to perform the 
colocalization studies in HEK293T cells. They are easily to transfect, grow fast and require 
only conventional medium. Despite the fact that these cells were derived from embryonic 
kidney tissue the real type of tissue to which HEK293T cells belong remains rather obscure. 
Indeed, recent publications propose that an immature neuronal tissue instead of epithelial cells 
was taken for the generation of HEK cells (Shaw et al., 2002) This group found many proteins 
in HEK293T cells, that are commonly present in neuronal tissue. Overall, HEK cells are well 
suitable if one needs a host for proteins but does not want to study the cell itself. In our study 
the cellular behavior is important since we aim at analyzing the Pex11 proteins in a 
reasonable cellular context. We will therefore perform our future cell biological experiments 
in fibroblasts as these represent well established cells to study peroxisomes.  
Additionally, we will expand our knowledge of the importance of certain domains and 
putative phosphorylation sites. Since we investigated only the double mutant (HsPex11α 
S159D/S161D and S159A/S161A) by now, the effects of the respective single mutations 
promise deeper insight into a possible regulation of HsPex11α. 
At a later point, we want to analyze the effects of different substances inducing oxidative 
stress on the regulation of Pex11 proteins. Here, it will be interesting to compare “young” to 
“old” cells, observing their capability to handle oxidative stress with regard to peroxisome 
proliferation. 
 
The analysis of the peroxisomal proliferation machinery in human cells might provide insight 
into a new mode of organelle proliferation based on constitutive and inducible fission 
processes and, potentially, on a close interaction with the ER. As mentioned above, 
HsPex11α contains a dilysine motif, known to be able to recruit coatomer (Passreiter et al., 
1998). Similarly, the C-terminus of RnPex11-1 contains a KxKxx motif. CHO-mutants, 
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defective for the coatomer, presented tubuled, elongated peroxisomes upon introduction of 
RnPex11-1 (Anton et al., 2000). As a consequence, a possible role for a cargo or retrograde 
transport from peroxisomes to the ER has been suggested (Lay et al., 2006).  
 
Eventually, our work may bring forth new aspects and strategies to analyze membrane 
dynamics and organelle proliferation at a molecular level, stimulating further studies.  
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5 Materials 
5.1 Buffers 
 
FSB 
 
10mM KOAc 
10% v/v glycerol 
10mM KCl 
50mM CaCl2 
pH=6.2 with HAc 
 
 
LYSIS BUFFER (for human tissue) 
 
20mM Tris HCl pH 7.5 
0.5mM EDTA disodium salt 
120mM KCl 
1mM DTT 
10% v/v glycerol 
+protease inhibitor cocktail (as recommended) 
 
 
10xPBS 
 
1.3M NaCl 
0.07M Na2HPO4 
0.3M NaH2PO4 
 
 
10xPBST 
 
PBS + 0.05% v/v Tween-20 
 
 
TBE 
 
89mM Tris 
89mM boric acid 
2.5mM EDTA disodium salt 
pH 8.2 (with HCl) 
 
 
TBS(T) 
 
50mM Tris 
150mM NaCl 
(0.05% v/v Tween 20) 
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TE 
 
10mM Tris 
1mM EDTA disodium salt 
pH 7.7 with HCl 
 
 
Buffers for alkaline lysis (DNA preparation) 
 
P1 
50mM Tris HCl pH 7.5 
10mM EDTA disodium salt 
100µg/ml RNAse A 
 
P2 
200mM NaOH 
1% w/v SDS 
 
P3 
3M KOAc  
pH 5 with HAc 
 
 
DNA PAGE gel  
 
6% v/v acrylamide/ bisacrylamide solution (39:1, provided by BioRad) 
4% v/v glycerol 
15µl TEMED 
15µl APS 
in TBE 
 
 
DNA PAGE sample buffer 
 
50% v/v glycerol 
50% v/v H2O 
0.01% w/v bromphenol blue 
 
 
STOP solution 
 
4M urea 
50% w/v sucrose 
5mM EDTA disodium salt 
0.01% w/v bromphenol blue 
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5.2 SDS PAGE/ Western blot solutions 
 
10% separation gel (use 7.5ml) 
 
1.5M Tris HCl pH 8.8      2.5ml 
30% acrylamide/ bisacrylamide solution (provided by BioRad)  3.3ml 
dH2O         4.1ml 
10%SDS        100µl 
mix and degas with vacuum pump 
20% APS        15µl 
TEMED        15µl 
 
 
5% stacking gel (use ~2.5ml) 
 
1.5M Tris HCl pH 6.8      1.25ml 
30% acrylamide/ bisacrylamide solution (provided by BioRad)  0.8ml 
dH2O         2.9ml 
10%SDS        50µl 
mix and degas with vacuum pump 
20% APS        15µl 
TEMED        7.5µl 
 
 
2x SDS Sample Buffer 
 
125mM Tris 
4% w/v SDS 
10% v/v 2-mercaptoethanole (1.43M) 
20% v/v glycerol 
0.01% w/v bromphenol blue 
 
 
5x SDS Sample Buffer 
 
the same applies as for 2x SDS Sample Buffer, but 2.5fold higher concentrated 
 
 
2x SDS Sample Buffer with urea 
 
100mM Tris 
4M urea 
4% w/vSDS 
40% v/v glycerol 
3.5% v/v 2-mercaptoethanole (250mM) 
0.01% w/v bromphenol blue 
 
 
running buffer 
 
25mM Tris 
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500mM glycin 
10% w/v SDS 
 
 
transfer buffer 
 
25mM Tris 
500mM glycin 
 
 
stripping buffer 
 
2M MgCl2 
100mM acetic acid 
 
 
Ponceau S staining solution 
 
0.2% w/v PonceauS 
3% w/w trichloracetic acid (TCA) 
 
5.3 Cell culture 
 
 
Dulbecco’s modified Eagle’s medium (DMEM) 
 
supplemented with 1%L-Gln, 10% FCS (fetal calf serum) and 1% Penicilline/ Streptomycin 
(“full medium”) 
 
inorganic salts mg/l 
 
CaCl2 (dry)  200 
Fe(NO)3.9H2O  0.10 
KCl   400 
MgSO4  97.70 
NaCl   6400 
NaH2PO4.H2O  125 
NaHCO3  3700 
 
other components mg/l 
 
D-glucose  4500 
phenolred  15 
sodium pyruvate 110 
 
amino acids mg/l 
 
L-arginine HCl 84 
L-cystine   48 
L-glutamine  584 (added separately) 
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glycine   30 
L-histidine HCl H2O 42 
L-isoleucine  105 
L-leucine  105 
L-lysine HCl  146 
L-methionine  30 
L-phenylalanine 66 
L-serine  42 
L-threonine  95 
L-trypthophane 16 
L-tyrosine  72 
L-valine  94 
 
vitamins mg/l 
 
D-calcium pantothenate 4 
choline chloride  4 
folic acid   4 
myo- inositol   7.2 
nicotinamide   4 
pyridoxal HCl   4 
riboflavin   0.4 
thiamine HCl   4 
 
penicillin/streptomycin solution and FCS added separately 
 
 
trypsin splitting solution 
 
0.5mg/ml trypsin, 0.22mg/ml EDTA (Titriplex III) in PBS 
 
 
fixation solution 
 
4% formaldehyde in PBS 
 
 
freezing medium 
 
DMEM + 1%L-gln + 10% DMSO + 15% FCS 
 
 
permeabilization solution  
 
0.3% Triton X-100 in PBS 
 
 
blocking solution for immunostaining 
 
1% BSA in PBST 
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mounting medium 
 
2.4g mowiol 4-88 (partly hydrolyzed polyvinylalcohol) 
6.0g glycerol 
6.0ml dH2O 
12.0ml 0.2M Tris HCl pH 8.5 
 
each additive added with one hour mixing in between; final incubation at 50°C for 2 hours 
with slight shaking; then 25mg/ml DABCO (1,4-Diazabicyclo-(2,2,2)octan) as bleaching- 
inhibitor were added, storage at -20°C 
for staining the nuclei (through staining the DNA) DAPI (4’,6-diamidino-2-phenylindol) was 
directly added to the mounting medium. Alternatively, coverslips were finally incubated in 
Hoechst dye solution (Hoechst 33342, 1µg/ml, 5’, RT), washed and mounted.  
5.4 E.coli media 
 
Luria Broth (LB) 
 
1% w/v bacto trypton 
0.5% w/v yeast extract 
0.5% w/v NaCl 
0.5% w/v D-glucose 
pH 7.2 with NaOH 
 
add if resistance was given 
30mg/l Kanamycin 
100mg/l Ampicillin 
20mg/l Tetracycline 
 
3% w/v agar for plates 
 
 
SOC 
 
2% w/v bacto tryptone 
0.5% w/v yeast extract 
10mM  NaCl 
2.5mM KCl 
10mM MgCl2 
10mM MgSO4 
20mM D-glucose 
 
 
YT 
 
1.6% w/v bacto tryptone 
1% w/v yeast extract 
0.5% w/v NaCl 
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5.5 Plasmids and Oligonucleotides 
 
5.5.1 Plasmids 
name description 
pCB234 pDEST53-GFP+ 
pCB322 pSilencer 2.1-U6 hygro (EGFP) 
pCB344 pENTR4 
pCB368 pCMV-mCherry-SKL 
pCB391 pDEST53-SNAPTEVTEV 
pCB402 pmCherry-ER 
pCB430 pcDNA-DEST53 
pCB435 pEGFP-HsmSCP2 
209 EXP53-GFP-HsPEX11B 
214 EXP53-GFP+-yPEX11delta stop 
215 HsPEX11A+STOP in pENTR4 
216 HsPEX11B+STOP in pENTR4 
217 HsPEX11C+STOP in pENTR4 
218 EXP53-GFP+-HsPEX11A+STOP 
219 EXP53-GFP+-HsPEx11B+STOP 
220 EXP53-GFP+-HsPEx11C+STOP 
222 EXP53-GFP+-yPEX25+STOP 
224 EXP53-GFP+-yPEX27+STOP 
227 S-A HsPEX11A+STOP in pENTR4, StrategyIII 
228 S-D HsPEX11A+STOP in pENTR4, StrategyIV 
229 HsPEX11B delta 78bp +STOP in pENTR4, Strategy VI 
231 EXP53-S-A HsPEX11A+STOP, StrategyIII 
232 EXP53-S-D HsPEX11A+STOP , StrategyIV 
233 EXP53-HsPEX11B delta 78bp +STOP, Strategy VI 
234 EXP53-codon 3 MUT yPEX11+STOP, StrategyVII 
235 EXP53-AtPEX11-1 
236 EXP53-AtPEX11-2 
237 HsPEX11A delta60bp +STOP in pENTR4 
238 EXP53+-AtPEX11-3 
239 EXP53+-AtPEX11-4 
240 EXP53+-AtPEX11-5 
241 EXP53+-HsPEX11Adelta60bp 
242 EXP53+-yPEX11delta54bp 
243 EXP53+-SNAPTEVTEV-HsPEX11A 
244 EXP53+-SNAPTEVTEV-HsPEX11C 
Table 5: plasmids used in this study 
5.5.2 Oligonucleotides/ Primers 
name sequence 
CB109 TTAGCTAGCGGTACCATGGTGAGCAAGGG 
CB110 CTAGATCTTTATAATTTGGACAGGTGGTGGCGCTTGTACAGCTCGTCCATGCC 
CB127 GATCCCAGATTCGACAACTGGAGATTCAAGAGATCTCCAGTTGTCGAATCTGTTTTTTGGAAA 
CB128 AGCTTTTCCAAAAAACAGATTCGACAACTGGAGATCTCTTGAATCTCCAGTTGTCGAATCTGG 
CB129 GATCCACACGCAAGAGCATATGTGTTCAAGAGACACATATGCTCTTGCGTGTTTTTTTGGAAA 
CB130 AGCTTTTCCAAAAAAACACGCAAGAGCATATGTGTCTCTTGAACACATATGCTCTTGCGTGTG 
CB131 GATCCGAGCTGTTCACCTATCAGATTCAAGAGATCTGATAGGTGAACAGCTCTTTTTTGGAAA 
CB132 AGCTTTTCCAAAAAAGAGCTGTTCACCTATCAGATCTCTTGAATCTGATAGGTGAACAGCTCG 
CB133 GATCCACAAGTGCACATGTGTCTCTTCAAGAGAGAGACACATGTGCACTTGTTTTTTTGGAAA 
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CB134 AGCTTTTCCAAAAAAACAAGTGCACATGTGTCTCTCTCTTGAAGAGACACATGTGCACTTGTG 
CB135 GATCCCTCAGCCACTGCAGGACCATTCAAGAGATGGTCCTGCAGTGGCTGAGTTTTTTGGAAA 
CB136 AGCTTTTCCAAAAAACTCAGCCACTGCAGGACCATCTCTTGAATGGTCCTGCAGTGGCTGAGG 
CB137 GATCCAGTGTACGCGCACACCCACTTCAAGAGAGTGGGTGTGCGCGTACACTTTTTTTGGAAA 
CB138 AGCTTTTCCAAAAAAAGTGTACGCGCACACCCACTCTCTTGAAGTGGGTGTGCGCGTACACTG 
CB139 GATCCTCCTCAGCATGTACCAGGCTTCAAGAGAGCCTGGTACATGCTGAGGATTTTTTGGAAA 
CB140 AGCTTTTCCAAAAAATCCTCAGCATGTACCAGGCTCTCTTGAAGCCTGGTACATGCTGAGGAG 
CB141 GATCCGTAGACACGCACGCTCTCTTTCAAGAGAAGAGAGCGTGCGTGTCTACTTTTTTGGAAA 
CB142 AGCTTTTCCAAAAAAGTAGACACGCACGCTCTCTTCTCTTGAAAGAGAGCGTGCGTGTCTACG 
CB983a GATCCGAGAAATCAGCATCCCAGGTTCAAGAGACCTGGGATGCTGATTTCTCTTTTTTGGAAA 
CB984a AGCTTTTCCAAAAAAGAGAAATCAGCATCCCAGGTCTCTTGAACCTGGGATGCTGATTTCTCG 
CB985 GATCCAGAGGGCACATGCATACACTTCAAGAGAGTGTATGCATGTGCCCTCTTTTTTTGGAAA 
CB986 AGCTTTTCCAAAAAAAGAGGGCACATGCATACACTCTCTTGAAGTGTATGCATGTGCCCTCTG 
CB987 GATCCGAACCTTTGTGATATCCTGTTCAAGAGACAGGATATCACAAAGGTTCTTTTTTTGGAAA 
CB988 AGCTTTTCCAAAAAAGAACCTTTGTGATATCCTGTCTCTTGAACAGGATATCACAAAGGTTCG 
CB989 GATCCAGCAAGTGTGTCTCTATCTTTCAAGAGAAGATAGAGACACACTTGCTTTTTTTTGGAAA 
CB990 AGCTTTTCCAAAAAAAGCAAGTGTGTCTCTATCTTCTCTTGAAAGATAGAGACACACTTGCTG 
CB991 GAGCTCTCTGACACCATGGACAAAGACTGCGAAATGAAG 
CB996 GGAGCGAGAATTTGTATTTTCAGGGTGAGCTATCCGAAAATCTCTATTTTCAGAGTGAGCCATGGGAGCT 
CB997 CCCATGGCTCACTCTGAAAATAGAGATTTTCGGATAGCTCACCCTGAAAATACAAATTCTCGCTCCAGCT 
CB998 AGCTGGAGCTCCCATGGCTCACTC 
  
  
 Pex11A-Hs-5 CCATGGACGCCTTCACCCG 
 Pex11A-Hs-6 CTCGAGCTAACGGGTCTTCAGCTTCATCTGAGG 
 Pex11A-Hs-7 ATCTTGGGCTGCGGCTTTCTCTTTCTTTGCCCTGTCACA 
 Pex11A-Hs-8 GAGAAAGCCGCAGCCCAAGATCCTCTTTGGTTCAGTGTGGCT 
 Pex11A-Hs-9 ATCCTGATCAGCATCTTTCTCTTTCTTTGCCCTGTCACA 
 Pex11A-Hs-10 GAGAAAGATGCTGATCAGGATCCTCTTTGGTTCAGTGTGGCT 
 Pex11A-Hs-11 GGCTCGAGCTAACGGGTCTTAAGCTTCATCTGAGGAGGATTGGATTTATAGATCCCCAG 
 Pex11B-Hs-5 CCATGGACGCCTGGGTCCG 
 Pex11B-Hs-6 CTCGAGTCAGGGCTTGAGTCGTAGCCAGG 
 Pex11B-Hs-7 GGTCTAGATATCTCGAGTCAGGGCTTGAGACGTCGCCAGAGGCCTAGTTTGTCCAG 
 Pex11G-Hs-1 TGGATCCGGATGGCGTCGCTGAGCGGCCTGG 
 Pex11G-Hs-2 CTCGAGTCAGGGGGTAGTGGCCTCGGCCT 
Table 6: oligonucleotides used in this study 
 
5.6 Human cell lines 
 
HEK293T human embryonic kidney cells (Invitrogen) 
 
6 Methods 
 
6.1 Molecular biology 
 
6.1.1 Restriction digest 
 
Digests were performed according to the manufacturer’s instruction unless otherwise stated. 
Usually one unit enzyme was used per microgram DNA. 
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6.1.2 Ligation 
 
Ligation was performed using Invitrogen’s Rapid Ligation Kit® according to the 
manufacturer’s instructions. The amount of vector-DNA and insert-DNA was adjusted to 
come as close as possible to the ideal molar ratio of 1:3 (vector:insert) depending on the 
length of the insert. The usual incubation time was 20-30 minutes unless otherwise stated.  
 
6.1.3 PCR 
 
The usual PCR mixture was  
 
1µl template (appropriate dilution of 1:100 - 1:1000) 
2µl of each primer (10µM) 
5µl of appropriate 10x buffer 
1µl dNTPs (10mM) 
1µl polymerase  
38µl TE (pH 8.0). 
 
All components were mixed and the solution was overlaid with 50-70µl of mineral oil to 
prevent vapour diffusion. PCR was performed with Pfu polymerase (30cycles), because Pfu 
exhibits a proof reading activity. For TA-cloning (e.g. in pGEM-T) PCR was continued with 
Taq polymerase (five cylces). The temperature setting was  
 
first cycle  95°C  5’ 
30 cycles 95°C 1’  
  - 1’ annealing temperature had to be adjusted to primers’ Tm 
  72°C 2’/kb if Pfu turbo was used the time could be halved  
last cycle 72°C 10’ 
 
The water phase of the PCR was loaded on an agarose gel for analyzing the DNA content. 
 
6.1.4 Gateway® reaction 
 
The gateway® technology provided by Invitrogen was used to create tagged proteins very 
conveniently. The tag is part of the destination vector, while the protein of interest is coded in 
the entry vector. Both vectors contain att-sites localized in such way that after the 
recombination performed by an enzyme mix, called clonase, the gene of interest is in frame 
with the tag. This product is called expression vector. The possibility to create a manifold of 
expression vectors by this recombination out of few educts saves time.  
The usual mixture and conditions were 
 
1µl of destination vector (150 ng/µl DNA) 
1µl of entry vector (150 ng/µl DNA) 
2µl clonase enzyme mix 
1µl 10x clonase buffer 
5µl TE pH 8.0 
 
for 2 hours at RT. After subsequent treatment with Proteinase K (10’, 37°C), the produced 
expression vector was transformed by electroporation. 
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6.1.5 Agarose gel electrophoresis 
 
Agarose gel electrophoresis was performed to separate DNA fragments. STOP solution was 
added to the DNA before loading onto the gel (1% agarose (Biozym or Sigma) in TBE with 
0.05‰ ethidiumbromid).  
Standard parameters: 100V (fixed), buffer: TBE 
 
6.1.6 DNA PAGE 
 
PAGE was performed to analyze small DNA fragments in the range of 20-100bp. Samples 
were mixed with DNA PAGE sample buffer and loaded onto gel with Fermentas’ o’Gene low 
range DNA ladder®. Electrophoresis was performed with TBE as running buffer (170Vmax, 
50mA). For visualization of the DNA the gel was incubated in 0.05‰ ethidium bromide in 
TBE for 30 minutes followed by a destaining in TBE for 15 minutes. 
 
6.1.7 DNA purification 
 
DNA fragments were separated on a 1% agarose gel. The gel piece containing the DNA of 
interest was cut out with a scalpel and transferred to a tube. Gel extraction and DNA elution 
was performed with Nucleospin Extract II® (Macherey & Nagel) according to the 
manufacturer’s instruction. The DNA amount after elution was analyzed by agarose gel 
electrophoresis.  
 
6.1.8 DNA precipitation 
 
The DNA solution was filled up to at least 100µl. Two volumes of i-propanol and 1/10th 
volume of 3M sodiumacetate was added. DNA was precipitated at -80°C and pelleted (10’, 
13000rpm, 4°C). The pellet was once washed in 70% v/v ethanol (-20°C), dried well, e.g. 
with a vacuum centrifuge (10’, 8000rpm, 40°C), and resuspended in TE.  
 
6.1.9 Plasmid- DNA preparation E.coli (alkaline lysis) 
 
A colony was inoculated and grown in 3ml of appropriate selective medium at 37°C over 
night, 1.5ml were harvested and centrifuged (1’, 13000rpm, RT). The cell pellet was 
resuspended in 300µl buffer P1 (see buffer section), subsequently 300µl buffer P2 and 300µl 
of buffer P3 were added with mixing steps in between. In order to remove all cell debris and 
proteins the solution was centrifuged (10’, 13000rpm, RT). The supernatant was transferred 
cautiously into a new tube, 650µl of 2-propanol were added, mixed and incubated for 10 
minutes at room temperature. Then the suspension was centrifuged (10’, 13000rpm, 4°C). The 
DNA pellet was washed with 70% ethanol (4°C) once, dried well and resuspended in 50µl 
TE. 
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6.1.10 Plasmid- DNA preparation E.coli (Promega Kit) 
 
A colony was inoculated and grown in 3ml of appropriate selective medium at 37°C over 
night, 1.5ml were harvested and centrifuged (1’, 13000rpm, RT). The following steps were 
performed according to the manufacturer’s instructions.  
 
6.1.11 Alignment for sequences 
 
In the case a plasmid was checked by sequencing, the obtained sequence was compared to the 
correct one by using a multiple alignment program available via http:// 
baboon.math.berkeley.edu/mavid/ (Bray and Pachter, 2003; Bray and Pachter, 2004). 
 
6.1.12 Transformation into E.coli 
6.1.12.1 Preparation of chemically competent E.coli 
 
Cells were inoculated in YT or LB medium O/N at 37°C. Subsequently 1ml of this culture 
was grown in 100ml YT medium to OD600=0.8 and centrifuged (3700rpm, 12’, 4°C). The cell 
pellet was washed in 15ml icecold FSB and incubated for 10 minutes on ice. After a further 
centrifugation step (3700rpm, 10’, 4°C), cells were resuspended in 8ml icecold FSB, 
aliquoted and stored at -80°C. 
 
6.1.12.2 Chemical transformation of E.coli 
 
DNA (in case of ligation: 10-15µl, in case of retransformation: 1-3µl of a suitable dilution) 
was added to 100µl of competent cells and incubated for 10-15 minutes at 4°C. This solution 
was heat shocked for 45 seconds at 42°C and immediately put on ice for 5 minutes. 1ml of 
YT medium was added, the solution was incubated for 30-45 minutes at 37°C for revival, 
centrifuged (30’’, 7000rpm, RT) and plated onto appropriate selective medium. 
 
6.1.12.3 Preparation of electrocompetent E.coli 
 
Cells were prepared as described for chemically competent E.coli, but were washed and 
resuspended in dH2O instead of FSB. 
 
6.1.12.4 Transformation of E.coli by electroporation 
 
50µl of electrocompetent cells were mixed with 2µl of DNA avoiding bubbles and transferred 
to a clean and sterile cuvettes (washed with soap & 70% EtOH, UV treatment for 30’). In 
order to avoid a short-circuit the cuvettes had to be wiped off prior to placing in the pulse 
controller. Pulse conditions were 1.7V, 25µF capacitance and 200Ω resistance resulting in an 
ideal time constant of about 3.4-4.3s. 1ml of SOC was added to the cuvettes and after 
resuspending the suspension, cells were transferred into a tube and revived 30 minutes at 
37°C. Subsequently cells were pelleted (7000rpm, 1’, RT) and plated onto appropriate 
selective medium. 
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6.2 Biochemistry 
6.2.1 Bradford assay 
 
An appropriate dilution of the sample was mixed with an 1:5 dilution of Bradford’s reagent  
and incubated at 30°C for 10-20’. Photometric absorption was measured at 595nm.  
 
6.2.2 SDS PAGE 
6.2.2.1 Gel preparation 
The separation gel was prepared first: All components, but APS and TEMED, were mixed 
and degassed for 10’. After addition of APS and TEMED (icecold) the solution was carefully 
filled in between the prepared glass plates and overlaid with i-amylalcohol. During 
polymerization the stacking gel had been prepared like the separation gel. After 
polymerization, the alcoholic layer was removed, the stacking gel solution was filled in and 
the comb was pulled in tightly avoiding bubbles.  
6.2.2.2 Sample preparation 
Samples were mixed with sample buffer (SB), incubated for 5’ at 95°C and centrifuged 
(13000rpm, 5’, RT). 
6.2.2.3 Electrophoresis 
The system was set up, the gel was fixed in the chamber. After removal of the comb, the slots 
were washed with dH2O and the chamber was filled with running buffer (RB). The prepared 
samples were loaded into the slots and the voltage had been applied (40mA constant, 170V 
max.) until the blue front reached the bottom of the gel. 
6.2.2.4 Western blotting (semi-dry) 
The stacking gel was cautiously removed and the separation gel was shortly incubated in 
transfer buffer before it was situated onto a nitrocellulose (NC) membrane of appropriate size. 
In order to guarantee enough transfer buffer during the whole blotting process a stack of filter 
papers was placed on the bottom and on the top between the electrodes of the blotting 
apparatus. Voltage had been applied (60mA constant (1.5mA/cm2), 25V max.) for two hours. 
The membrane was then washed once in TBST, incubated in blocking solution for one hour, 
subsequently briefly washed and incubated with the primary antibody for 2 hours at RT. 
Incubation with the secondary antibody was performed for 1.5-2 hours following a washing 
procedure (3x for 15’ each in TBST). The detection assay was performed using Pierce Super 
Signal West Pico Chemiluminescent Substrate (HRP) or BioRad Immunstar WesternC® for 
more sensitive detection. 
 
6.2.2.5 Stripping a NC-membrane 
In some cases it was necessary to perform a second assay (e.g. another antibody) on the same 
NC membrane. Therefore the antigen-antibody interaction had to be weakened and then 
eliminated. The membrane was incubated with stripping buffer 10’ at RT and washed in 
TBST O/N or at least 3 times for 15’. The membrane was then treated as described before.  
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6.2.2.6 PonceauS staining 
The NC membrane was incubated in PonceauS staining solution for 1 to 2 minutes, 
subsequently destained in dH2O for higher contrast. For complete destaining the NC 
membrane was incubated in TBST. 
 
6.3 Cell culture 
6.3.1 Growing conditions 
 
Cells were grown in DMEM + L-glutamine + FCS + penicillin/ streptomycin (referred to as 
“full medium”) at 37°C with 5% v/v CO2 (incubator: Binder CB150). Any sterile operations 
were performed in a laminar flow hood (Holten LaminAir, HB2438). 
 
dish diameter volume of medium 
10 cm or 75cm2 flask 10 ml 
3 cm (6-well) 2 ml 
12-well 1 ml 
24-well 750µl 
48-well 500µl 
96-well 100µl 
 
6.3.2 Splitting/ dry 
 
All medium was removed and cells were washed with PBS once. 1.5 ml trypsin EDTA 
solution was added and removed immediately. The cells were incubated for 5 minutes at 37°C 
and the appropriate amount of full medium was added to dilute the cells. They were 
thoroughly resuspended and transferred to a new dish. 
 
6.3.3 Splitting/ wet 
 
The same applies as for dry splitting, but trypsin was not removed. After resuspending the 
cells, they were centrifuged (700rpm, 4’, RT) and resuspended in the appropriate amount of 
full medium in order to dilute. 
 
6.3.4 Freezing 
 
Cells were split as described before and resuspended in freezing medium. Cells were frozen in 
aliquots of 1600µl for at least 24h at -80°C in a cool box containing isopropanol for a constant 
freeezing gradient, then transferred in liquid nitrogen. 
 
6.3.5 Thawing 
 
The cryotube (containing 1.5ml of cell suspension) was put at 37°C in order to thaw the cells 
as quickly as possible. The thawed solution was then diluted with 5ml DMEM, centrifuged 
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(700rpm, 3’, RT), resuspended in 7ml of full medium and transferred to a 25cm2 flask (T25) 
for incubation. 
 
6.3.6 Transfection with FuGene 6 (Invitrogen) 
 
First, cover slips (12mm glass circles, Sigma) had to be prepared. They were left in 
HNO3/H2SO4 (1:2) O/N, washed in dH2O 10 times, then incubated in 1g/l EDTA for three 
hours before getting thoroughly rinsed with dH2O 10 times. Prepared cover slips were stored 
in 95% ethanol.  
For microscopy, cells were grown directly on cover slips or, for whole cell extracts seeded in 
100mm dished. Cells were prepared and transfected according to the manufacturer’s 
instructions. Usual parameters (unless otherwise stated): total amount of DNA: 1µg, 3µl 
FuGene, incubation time: 20h 
 
6.3.7 Whole-cell extracts (lysis with sample buffer) 
 
Cells were washed once with PBS, 20µl of 2x sample buffer with urea (each 6-well) 
preheated at 95°C was added and cells were scraped with a sterile cell scraper and transferred 
to a new tube. In case of a slimy consistence the extracts were sonicated twice (75% intensity, 
50% cycle time, 7’’, 4°C). An aliquot was loaded onto a SDS-PAGE gel.  
 
6.3.8 Whole cell extracts (lysis with lysis buffer) 
 
Cells were trypsinized (wet method) and resuspended in appropriate volume of lysis buffer 
(usually 100-200µl for 100mm dish). After breaking the cells for 15’ at 4°C on a rocking 
platform, they were additionally treated with a mini-eppendorf-potter and/or sonicated.  
 
6.3.9 Optimizing antibiotic selection conditions (“antibiotic 
titration”) 
 
Some substances inhibit the growth of a wide range of prokaryotic and eukaryotic cells. 
Nevertheless they are called antibiotics. It was necessary to determine the ideal concentration 
of each antibiotic for each cell line. An equal number of cells (about 20.000) was seed into 
every well of a 6-well and incubated for 24 hours before the antibiotic treatment was started: 
Cells were washed, the medium is changed and different amounts of the antibiotic solution 
are added to each well, recurring every three days. Cells were inspected for viability every 
day. The optimal antibiotic concentration should cause massive cell death after 4-7 days and 
kill all cells within 10-14 days. This concentration was used to keep cells on selective 
conditions, but to initiate selection the concentration was doubled. 
 
6.3.10 Establishing stable cell lines after plasmid transfection 
 
Cells were transfected as described above. One day after the transfection cells were split in 
different densities and incubated for 24h before the selective agent was added. Then growth 
and apoptosis was observed while changing the medium (with antibiotic) every 2-3 days. 
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After all nontransfected cells were killed, the 100mm dish were split in a 96-well and diluted 
in such way, that only one cell remained in one well. Medium with selective agent was 
changed every 2-3 days until cells reached full density. Dense cells were split and transferred 
to a 48-well followed by subsequent growth and splitting until the cells fully covered a 
100mm dish.  
 
6.3.11 4-PBA treatment 
 
Cells were seeded in normal density and incubated 10 days in full medium supplemented with 
5mM final concentration sodium 4-phenylbutyrate (provided by Calbiochem).  
 
6.3.12 siRNA/ shRNA 
 
Suitable 19-mer siRNA fragments were designed using the software OligoEngine 
Workstation 2. The fragments with the highest potency and fewest BLAST hits (nucleotide 
blast, BLASTN, Altschul et al., 1997) were chosen. A negative control was designed for each 
siRNA by scrambling its oligonucleotides. 
All siRNA were cloned into pSilencer 2.1-U6 hygro (BamHI, HindIII) and sequenced. 
 
6.3.13 Labeling the SNAP®-tag 
 
Medium was removed from cells expressing SNAP fusion proteins and the labelling solution 
was added directly onto the cells (1:200 dilution of stock; stock: 400µM TMR-Star or 1mM 
BG-505 in DMSO) and incubated for 15’ (TMR-Star) or 30’ (BG-505) at 37°C. Then, cells 
were washed twice and incubated with full medium for 30’ to remove unreacted substrate 
leaching out of the cells followed by a last washing step. Then, cells were ready for live cell 
imaging or fixing. 
 
6.3.14 SNAP® -vista technology 
 
For direct labeling the SNAP® fusion proteins on a SDS-gel, 2µl labeling solution was added 
to 18µl of sample in lysis buffer (recommended composition of lysis buffer identical with 
lysis buffer described above) and incubated for 20’ at RT in the dark. Then, sample buffer 
was added and the SDS-gel was run. After running, the bands were made visible by excitation 
with an UV-illuminator. 
 
6.4 Microscopy 
6.4.1 Fixation of human cells with formaldehyde 
 
Cells were washed twice in PBS for five minutes, incubated for 10-15 minutes in fixing 
solution, washed in PBS three times for five minutes and embedded in 20-30µl moviol onto a 
micro slide. 
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6.4.2 Immunostaining 
 
Cells were fixed as described above. Directly after fixing, cells were permeabilized in 0.1% 
TritonX-100 in PBS (10’,RT). Then, cells were blocked in blocking solution. After washing 
(5’,RT), cells were incubated with the primary antibody solution (PBST, 1h,RT) and after 
subsequent washing steps (3x 5’,RT) stained with the secondary antibody solution 
(PBST,1h,RT). After a final washing procedure (3x 5’,RT), cells were mounted as described 
above.  
 
6.4.3 Fluorescent microscope 
 
Zeiss Axioplan2, objective: Plan-ApoChrom 63x, 1.4, light source: Zeiss FluoArc +N HBO 
103; CCD camera: Pursuit B/W monochrome PR1600 + DualView imager, software: Spot 
v4.6.  
 
6.4.4 Confocal laser scanning microscope (CLSM) 
 
Zeiss Axioplan2 + Zeiss LSM 510 META, objectives: Plan-ApoChrom 63x, 1.4; α-Plan-
Fluar 100x, 1.45, software: Zeiss operating software AIM (expert mode), excitation by laser: 
488nm for GFP, 561nm for dsRED and mCherry, 633nm for IR-dyes and 405nm for Hoechst. 
Emission settings: DsRed/ mCherry: HFT 405/488/561, NFT 515, LP 585; GFP: HFT 488, 
NFT 565, LP 505; Hoechst: HFT 405/488/561, NFT 490, BP 470-525; far red: HFT 
405/514/633, NFT 565, LP 650 
 
6.4.5 Live cell imaging 
 
Live cell imaging was performed using the Zeiss LSM5 LIVE DuoScan system, objectives 
Plan-ApoChrom 63x, 1.4; software: Zeiss operating software AIM (expert mode), excitation 
by laser: 488nm for GFP, 535nm for dsRED and mCherry and 405nm for Hoechst. Emission 
settings as indicated above. 
 
6.4.6 Image handling 
 
Images were handled with Zeiss Image Software AIM® and ImageJ. Figures were arranged 
with Corel Draw 12.  
 
 
 
6.4.7 Deconvolution and 3D reconstruction 
 
Deconvolution and 3D rendering were performed with “Iterative Deconvolve 3D”, 
“Diffraction PSF 3D” and “VolumeJ” (Abramoff and Viergever, 2002), plugins of ImageJ. A 
representative crop of each channel was deconvolved (low pass filter (for x and y dimension) 
1.0, no Wiener filter, Z-direction low pass filter 1.0, maximum number of iterations 100, 
termination if mean delta is smaller than 0.01%) using the appropriate PSF. This was used as 
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input for 3D rendering (Raytrace algorithm, gradient no index, Scale 2.0, Classifier threshold 
128.0, Classifier deviation 2.0). Finally, channels were coloured and merged.  
 
6.4.8 Counting of peroxisomes 
 
Images from the CLSM were filtered by a median filter (radius 1.0), despeckled (radius 1.0), 
converted to 8-bit and thresholded using the “Multithresholder”, a plugin of ImageJ (threshold 
“Maximum Entropy”), to highlight the peroxisomal fluorescence. After applying the 
“Watershed” segmentation algorithm to separate neighbouring individual peroxisomes from 
each other, one cell was encircled manually and the particle analysis of ImageJ counted the 
number and area of each dot of a given category. Four categories have been set up (CAT I 0-
0.35µm, CAT II 0.36-0.66, CAT III 0.37-0.95µm, CAT IV 0.96-3.6µm diameter) and 50 
randomly chosen cells for each construct were counted. 
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‘’ second 
aa  amino acid 
BG benzylguanine 
CHO(-K1) chinese hamster ovary cells, (K1) 
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ER endoplasmic reticulum 
hAGT human alkylguanine transferase 
HEK human embryonic kidney 
mPTS peroxisomal membrane targeting sequence 
ORE oleate-responsive element 
PBA sodium 4-phenylbutyrate 
PMP peroxisomal membrane protein 
PPAR peroxisome proliferator activated receptor 
PPRE peroxisome proliferator responsive element 
PSF point spread function 
PTS peroxisomal targeting sequence 
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VLCFA very long chain fatty acid 
  
At Arabidopsis thaliana 
Cb Candida boidinii 
Hs Homo sapiens 
Sc Saccharomyces cerevisiae 
 
additionally, standardized usage of abbreviations of nucleotides and amino acids (one 
and three letter code) was applied 
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 i 
SUMMARY 
 
Peroxisomes are vital single membrane-bound organelles present in all eukaryotic cells. Their 
function is mainly associated with lipid metabolism and they enclose hydrogen peroxide-
generating and degrading enzymes. Peroxisomes are highly versatile organelles that quickly 
adjust their shape, size, number and protein content according to the cellular requirements. In 
humans, defects in peroxisome biogenesis lead to devastating diseases such as the Zellweger 
syndrome. Over 30 proteins, the peroxins, are involved in peroxisome biogenesis. In the yeast 
Saccharomyces cerevisiae, peroxins of the PEX11-family, namely PEX11, PEX25 and 
PEX27, participate in peroxisome proliferation. Indeed, yeasts lacking PEX11 present fewer 
and larger peroxisomes than wild type cells. Orthologues of the yeast PEX11-proteins, 
PEX11α, β, γ and PEX11-1 to -5 have been identified in human and plants, respectively. 
 
We sought to analyze the regulation of peroxisome proliferation through the PEX11-protein 
families in yeast, plant and human cells. This thesis focuses on human cells, where we 
performed co-expression studies using mCherry-SKL as peroxisomal matrix marker. We 
statistically described the effects of the different overexpressed GFP-Pex11 fusion proteins on 
peroxisome size and number. To pinpoint the molecular role of the Pex11 proteins we 
analyzed the overexpression effects over time. We further analyzed Pex11 proteins harboring 
point mutations and domain deletions. Moreover, we established stable cell lines expressing 
either peroxisomal marker proteins or a SNAP-TEV tagged version of Pex11. This tag 
enables to perform live cell imaging as well as biochemical experiments.  
 
Our analysis of ten proteins of the Pex11 family provided interesting hints on the conservation 
of the peroxisomal proliferation machinery between yeast, plant and human cells.  
   
 ii 
ZUSAMMENFASSUNG 
 
Peroxisomen sind wichtige, von einer einzelnen Membran umgebene Organellen, die in allen 
eukaryotischen Zellen vorkommen. Ihre Funktion betrifft hauptsächlich den 
Lipidstoffwechsel; sie enthalten auch Wasserstoffperoxid generierende und abbauende 
Enzyme. Peroxisomen sind sehr wandlungsfähige Organellen, die ihre Form, Größe, Anzahl 
und Proteininhalt rasch an die zellulären Anfordernisse anpassen. Bei Menschen führen 
Defekte in der Peroxisomenbiogenese zu verheerenden Krankheiten, wie etwa das Zellweger 
Syndrom. Über 30 Proteine, die Peroxine, sind in die Peroxisomenbiogenese involviert. In der 
Hefe Saccharomyces cerevisiae nehmen die Peroxine der Pex11 Familie, nämlich Pex11, 
Pex25 und Pex27 an der peroxisomalen Proliferation teil. Tatsächlich sind in Hefen, 
disruptiert für das PEX11 Gen, weniger und größere Peroxisomen vorhanden als in 
Wildtypzellen. Orthologe der Hefe-Pex11 Familie wurden in Säugetieren (Pex11α, β und γ) 
und Pflanzen (Pex11-1 bis -5) gefunden.  
 
Wir analysierten die Regulation der peroxisomalen Proliferation durch die Pex11 
Proteinfamilien in Hefe, Pflanzen und Menschen. Diese Arbeit beschäftigt sich mit humanen 
Zellen, wo wir Coexpressionsstudien mit mCherry-SKL, einem peroxisomalen Matrixmarker, 
durchgeführt haben. Des weiteren haben wir die Effekte der verschiedenen überexprimierten 
GFP-Pex11 Fusionsproteine auf die Größe und Anzahl der Peroxisomen statistisch 
beschrieben. Zudem analysierten wir die Überexpressionseffekte der GFP-Pex11 
Fusionsproteine über einen größeren Zeitrahmen hinweg, um die molekulare Rolle der Pex11 
Proteine genauer bestimmen zu können. Weiters untersuchten wir bestimmte 
Punktmutationen sowie Domänendeletionen einzelner Pex11 Proteine. Zusätzlich etablierten 
wir stabile Zelllinien, sowohl für die Expression eines peroxisomalen Matrixmarker-Proteins, 
als auch für SNAP-TEV getaggte Pex11 Fusionsproteine. Dieser Tag ermöglicht live cell 
imaging sowie biochemische Experimente.  
 
Unsere Analyse von zehn Proteinen der Pex11 Familie hat interessante Hinweise auf die 
evolutionäre Konservierung der peroxisomalen Proliferationsmaschinerie zwischen Hefe, 
Pflanzen und Menschen geliefert. 
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